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Abstract  
Abstract 
 
Natural products represent a remarkable source of lead molecules for drug 
discovery, given their impressive structural diversity and their still unexplored 
potential. Considering that more than 90% of the world’s biodiversity still waits 
to be investigated, Nature continues to be a gold mine of new chemotypes and 
pharmacophores. Thus, taking into account all the potential sources, including 
plants, fungi, bacteria, and marine environment, approximately one-third of all 
New Molecular Entities (NMEs) approved by Food and Drug Administration 
(FDA) derives from natural products. In this context, the research work reported 
in this Ph.D. thesis has been focused on the phytochemical investigation of plants 
belonging to the Iranian and Northern African flora, in order to discover and 
rationalize their pharmacological potential. In particular, the first part of my 
work has been devoted to the characterization of the polyacetylene fraction of 
Echinophora platyloba, which pointed out a new interesting TRPA1 modulating 
activity of C14 polyacetylenes isolated from this Iranian endemic plant. 
Subsequently, the bio-guided fractionation of the apolar extract obtained from 
Daucus virgatus, a Tunisian endemic plant, led to the isolation of angeloylated 
germacranolides showing a promising Plasmodium transmission blocking 
activity. Moreover, the complete phytochemical characterization of D. virgatus 
apolar extract has resulted in the isolation of additional antiproliferative 
secondary metabolites. Part of my Ph.D. project has been spent at University 
College of Dublin (UCD), to design and initiate a synthetic strategy for the 
preparation of daucovirgolide G, the angeloylated germacranolide that showed 
the most promising anti-malarial activity, among all those isolated from D. 
virgatus. The total synthesis of daucovirgolide G, which is still in progress, will 
have as final goal the preparation of the active compound and of several 
analogues to be pharmacologically evaluated. 
The results obtained during my Ph.D. have been reported in nine papers already 
published or ready for publication. 
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CHAPTER 1 
 
NATURAL PRODUCTS: A NEVER-ENDING INSPIRATION 
FOR DRUG DISCOVERY 
 
Natural products can be defined as secondary metabolites produced by natural 
sources, with the aim of ensuring an evolutionary advantage to the organisms that 
produce them. Indeed, unlike the primary metabolites (nucleic acids, proteins, fats, 
and carbohydrates), natural products are not necessary for survival, but they play an 
important role in defending terrestrial and marine organisms from predators or 
external threats, and in the interaction between species. Biological processes 
involved in the formation of secondary metabolites are essentially three: glycolysis, 
Krebs cycle, and photosynthesis; these metabolic reactions are responsible for the 
synthesis of intermediates, such as shikimic acid, acetyl coenzyme A (acetyl-CoA), 
mevalonic acid and 1-deoxyxylulose-5-phosphate, which provide a potentially 
unlimited number of natural products. In fact, due to different reasons, like 
environmental changes, chemicals, viruses etc., it can be seen that the secondary 
metabolism varies depending on the specific organism or species. Hence the 
extraordinary structural variability associated to natural compounds.1 
Historically, many diseases have been treated utilizing natural remedies; over 
centuries, natural products have retained their relevance in the drug discovery 
process, even overcoming the slight downturn determined by the development of 
combinatorial chemistry and high-throughput screening (HTS). Thus, if we do not 
simply consider the number of natural products which effectively become final drugs, 
but also the number of new chemical entities (NCEs) inspired by the “Nature’s 
treasure trove of small molecules”, it seems to be clear that this field of research 
continues to be of remarkable impact. Suffice to say that in a 30-year period, of 175 
small molecules approved as new drugs with anticancer activity by FDA, or similar 
organizations, almost 50% is composed of natural products or compounds arising 
from their scaffolds.2 Besides, a huge sense of optimism has been brought to the 
worldwide research in the natural products field, by the award in 2015 of the Nobel 
Prize in Physiology or Medicine to William C. Campbell and Satoshi Omura, for the 
discovery of the microbial natural products avermectins,3 active against 
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onchocerciasis and lymphatic filariasis, and to Youyou Tu, for the discovery of 
artemisinin, an antimalarial natural product isolated from Artemisia annua L.4 This 
milestone provides a remarkable illustration of the value reached by the natural 
products-based drug discovery and opens the way to new challenging achievements 
in this field.5  
 
1.1 Plants as a source of natural products 
 
Since the dawn of time, mankind has been assisted by Nature to gain useful 
remedies to treat all kinds of illness. There is a huge wealth of knowledge on the 
use of medicinal plants that is possible to find in the traditional medicine from 
all over the world. Taking advantage of the known information handed down 
over time about the healing properties of some plant species, a specific line of 
research has led to the isolation of several new natural products with a broad 
variety of pharmacological properties. The study of medicinal plants used in 
traditional medicine, focusing on the active metabolites responsible for the 
pharmacological effect, is termed ethnopharmacology, and this kind of scientific 
approach has resulted in the discovery of many well-known pharmaceuticals. 
One of the better examples is galanthamine,6 an alkaloid derived from Galanthus 
and Leucojum species (Amaryllidaceae), plants used for centuries in Eastern 
Europe as a remedy for neurological conditions. Currently, galanthamine is used 
as anti-Alzheimer’s drug and it represents a successful illustration of an 
ethnopharmacology-driven development of a drug starting from a natural source. 
Another interesting compound is represented by prostratin,7 a 12-deoxyphorbol 
ester isolated from Homalanthus nutans (G. Forst.) Guill. (Euphorbiaceae), a 
small rainforest tree utilised by Samoan healers to cure hepatitis (Fig. 1.1). 
Prostratin is a candidate lead for treating AIDS and clinical trials are currently 
underway.  
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Figure 1.1 Structures of galanthamine and prostratin 
 
These two drugs are reported to give an example of the most recent application of 
the ethnopharmacology to the modern drug discovery. When there is a lack of 
information about the pharmacological use of a plant in the traditional medicine of a 
specific area, natural extracts can be screened using functional biological assays; 
after selecting the most promising fractions, it is possible to purify and identify 
natural compounds responsible for the activity. Following simple instructions for the 
biological screening of extracts, an enhanced efficacy of the assay is obtained. For 
example, a prefractionation of the crude extract deriving from the plant, using normal 
phase or reverse phase chromatography, is undoubtedly necessary. Fractionation 
would provide less-complex samples, certainly more suitable for the sensitive 
biological text.8 
In conclusion, utilizing different kinds of approaches, the research of new natural 
leads from plants is endless; all the extracts which were screened for a specific 
pharmacological activity, have to be considered as “uninvestigated” with respect to 
other pharmacological properties. Therefore, the continuing success of plant-derived 
drug discovery proves that, with the correct tools, it is still possible to gain the best 
results from the world of natural products.9 
 
1.2 The role of synthetic chemistry in the natural products field 
 
The Achille’s heel of a natural products-based drug discovery is often 
represented by the limited amount of promising secondary metabolites present in the 
natural sources, thus making it difficult to perform additional biological studies or to 
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explore in detail the structure-activity relationship (SAR) of new natural leads. 
In this context, synthetic chemistry provides a useful tool to ensure sufficient 
quantities of compounds, which would be used in the drug development process. 
It should be mentioned that the structural diversity of natural products offers the 
opportunity to develop new synthetic strategies and methodologies in order to 
achieve advanced levels of knowledge in organic chemistry, explaining the 
reason why synthetic chemists have long been fascinated and inspired by natural 
compounds. Another important goal reached by applying synthetic chemistry to 
natural products’ field is to confirm the structures of isolated compounds, in 
some cases leading to the assignment of absolute configuration. 
There are several strategies adopted by organic chemists for the efficient synthesis of 
chemical entities’ libraries employed for pharmacological screening: Diversity 
Oriented Synthesis (DOS), Function Oriented Synthesis (FOS) and Target Oriented 
Synthesis (TOS).10  
DOS is based on the development of libraries constituted of structurally complex and 
diverse small molecules, differing in stereochemistry and skeletal arrays. Screening 
of such compounds can provide key informations about the identification of 
therapeutic protein targets, along with a reasonable number of hits set to be 
optimized. If the mechanism of action of a natural compound is known, an interesting 
strategy is represented by FOS, which is focused on the function of the molecule 
rather than its structure; applying this method it is possible to develop analogs with 
a simplified structure by only including the activity-determining structural features.11  
Lastly, Target Oriented Synthesis (TOS) allows chemists to prepare bioactive 
compounds using a retrosynthetic analysis; thus, starting from a structurally complex 
target, is possible to find a simple and small molecule that can be utilized to start the 
synthesis. 
The combination of the mentioned synthetic methodologies, along with the 
kaleidoscopic chemical structures created by Nature, has provided the possibility to 
bridge the gap between research in the natural products’ field and drug discovery. 
This concept is demonstrated by two recently approved drugs: trabectedin and 
ingenol mebutate; due to their lower abundance in the natural source, it would be 
impossible to reach the clinical phase, without the involvement of a proper synthetic 
strategy.  
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Trabectedin (Fig. 1.2),12 isolated from the Caribbean tunicate Ecteinascidia 
turbinate, was synthesized by PharmaMar, starting from cyanosafracin B, a natural 
product readily available using fermentation technology. 
 
 
 
Figure 1.2 Trabectedin isolated from Ecteinascidia turbinate 
 
The synthetic approach was inspired by the total synthesis of trabectedin designed by 
Corey in 1996. This molecule has been approved since 2007 for the treatment of 
advanced soft tissue sarcoma, under the name Yondelis®, and then in 2009 for the 
treatment of ovarian cancer. Currently, 21 open studies concerning Phase I to Phase 
III are present.13  
Another powerful example, that explains the key role of the total synthesis in drug 
discovery, is represented by ingenol mebutate (Fig. 1.3), a macrocyclic diterpene 
ester isolated from Euphorbia peplus L., a species belonging to Euphorbiaceae 
family, mostly distributed in Europe and traditionally used to treat skin diseases. In 
2012, a gel containing ingenol mebutate (Picato®, Leo Pharma A/S, Ballerup, 
Denmark) was approved by FDA and the European Medicines Agency (EMA) for 
the treatment of actinic keratosis, and a clinical research addressed to the application 
to other cancer types is still ongoing.14 The active compound can be recovered from 
the natural source as 1 mg per kilogram of plant material, suggesting that this option 
cannot be invoked. Given the complexities to design a suitable for large-scale 
synthesis of ingenol mebutate, the initial process included the isolation of 
unesterified diterpene ingenol from the closely related plant, Euphorbia lathryis L., 
using the liquid–liquid isolation procedure described by Appendino et al.15 Then, 
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chemists of LEO Pharma were able to prepare the desired active product employing 
a three-step process, starting from natural ingenol. Recently, the Baran group 
designed synthetic routes in order to obtain the active compound and some 
analogues; in this way, it may be possible to explore new pharmacological targets. 
For example, modifications of the angelate ester moiety seem to produce new 
promising drug candidates, that could be employed in highly active antiretroviral 
therapy (HAART) against HIV.16 
 
 
 
Figure 1.3 Structure of ingenol mebutate 
 
For many years, chemists have focused their attention on the development of 
synthetic strategies “to build” the complex structures of natural products; the 
achievements in this challenging field during the last century have been astonishing. 
In addition to its fascinating beauty, total synthesis provides an important opportunity 
to better understand biological processes and to develop new pharmaceutically 
promising molecules. Synthetic chemists have increasingly realized that they could 
integrate their synthetic efforts with biological studies to provide more helpful total 
synthesis. 
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CHAPTER 2 
 
TECHNIQUES AND METHODS EMPLOYED IN THIS STUDY 
 
The scientific research in the field of natural products requires different steps; 
first of all, there are a number of procedures that is possible to employ, in order to 
achieve the isolation and purification of compounds from a natural source. Thus, the 
application of spectrometric and spectroscopic techniques ensures the structural 
determination of new natural molecules; finally, the assignment of relative and 
absolute configuration is carried out through the analysis of information deriving 
from NMR data, computational approaches, or with the derivatization of the natural 
product with chiral derivatizing agents (CDA).  
 
2.1 Isolation procedures 
 
The isolation of natural products represents a crucial step because, depending on 
the amount of the available biological material, it is necessary to employ various 
analytical and preparative chromatographic methods, in order to reach the best 
conditions to obtain the optimal separation and isolation of new natural molecules. 
First, the biological material is extracted with an organic solvent, such as methanol. 
Then, the crude extract is partitioned between solvent with different polarity. In some 
cases, a modified Kupchan’s method1 can be used as follows:  
• The methanol extract is dissolved in a mixture of 10% H2O/MeOH and 
partitioned against n-hexane. 
• The water content (% v/v) in the MeOH extract is adjusted to 30% and 
partitioned against CHCl3. 
• MeOH is removed from the aqueous phase by evaporation, and then the 
aqueous phase is extracted with n-BuOH. 
Applying this method, four extracts (n-hexane, CHCl3, n-BuOH and H2O extracts), 
containing molecules with increasing polarity, can be obtained. Having reached this 
point, crude extracts are further fractioned, applying sequential chromatographic 
procedures, which involve methods with a high loading capacity and not expensive 
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stationary phases during the first step of separation. Subsequent purifications require 
techniques which demand smaller samples (HPLC, for example). 
MPLC (Medium Pressure Liquid chromatography) is one of the various preparative 
chromatography techniques, based on the use of a medium pressure to facilitate the 
transition of the liquid mobile phase through the stationary phase, which consists of 
a normal or reverse solid phase (usually silica gel resin). MPLC is widely used in the 
pharmaceutical, food, and chemical industries and many applications are possible in 
natural product isolation. The pressure normally used is about 5-40 bar, and can be 
loaded a sample weighing generally 100 mg-100 g.2 
HPLC (High Performance or High-Pressure Liquid Chromatography), represents a 
helpful technique used in the last step of the purification process, to afford pure 
compounds in high yields. The stationary phase may consist of normal or reverse 
phase silica gel, depending on the physicochemical properties of the sample to purify. 
Additionally, it is possible to employ chromatographic columns equipped with a 
chiral stationary phase, in order to perform enantiomeric separations.3 
After achieving the isolation of a new natural product, the next step envisages the 
characterization of its structure and the subsequent submission of the molecule to 
pharmacological assays. In our group this crucial part of the work is mainly carried 
out using NMR spectroscopy and mass spectrometry, taking advantage of the 
equipment available at the CSIAS center of the Department of Pharmacy. 
 
2.2 Mass spectrometry 
 
Mass spectrometry represents a useful analytical tool, used in particular in 
the organic chemistry field, which allows determining the elementary formula of 
unknown compounds, measuring their molecular masses. A molecule, to be 
analyzed, must be ionized and then separated on the basis of its mass/charge 
(m/z) ratio; once accelerated by an electric field, charged molecules can be 
detected by an analyzer, which separates different ions on the basis of their (m/z) 
ratio. Results of the analysis are displayed as spectra of the relative abundance 
of ions as a function of the m/z. The mass spectrometer can be divided into three 
core parts: ionization source, analyzer, and detector.4 A large part of compounds 
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described in the following chapters has been analyzed by Electrospray Ionization 
(ESI) mass spectrometry through an Orbitrap system. 
Electrospray ionization (Fig. 2.1) has played a key role in the development of mass 
spectrometry, due to its utilization as a soft ionization source for analysis of 
biomolecules. ESI can efficiently be coupled with HPLC, for example, to easily 
perform MS analysis of complex mixtures. The molecule of interest is usually 
dissolved in water mixed with organic solvents (methanol or acetonitrile), and the 
solvent containing the analyte is dispersed by electrospray into fine droplets. The 
particles formed with the help of electrospray, through a heated capillary carrying a 
potential difference, are subjected to further solvent evaporation, until the point that 
they “explode”, forming many smaller and stabilized droplets.5 
Due to the potential difference of the capillary, each droplet of the spray carries 
positive or negative charges, causing protonation or deprotonation of the analytes, 
which become ions. The ions displayed by mass spectrometry are ions created by the 
addition of a hydrogen cation, and denoted as [M+H] +, or of another cation, for 
example, sodium, [M+Na] +; the removal of a hydrogen nucleus, can create [M−H] 
− anion. Multiply charged ions, [M+nH] n+ can be also observed.6 
 
 
 
Figure 2.1 ESI mass spectrometry 
 
Nitrogen is often used as carrier gas in order to help the liquid nebulization and the 
evaporation of solvent presents in the droplets. 
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High-resolution mass spectrometry (HRMS) is an excellent technique, which ensures 
the determination of accurate masses of analyzed ions; the instrumental systems 
comprise Fourier-transform ion cyclotron resonance (FT-ICR), time-of-flight (TOF), 
and Orbitrap mass spectrometry (Fig. 2.2). 
Orbitrap mass spectrometry takes its name from the analyzer system, which utilizes 
orbital trapping of ions that in an electrostatic field rotate around the central 
electrode, oscillating along it. The frequency of the oscillations is not the result of 
the ion speed and it is inversely proportional to the square root of the (m/z). The ions 
oscillations are transformed by Fourier transformation to give individual signals with 
high resolving power (up to 200,000), and high-accuracy mass determination (1-2 
ppm). In 2003, Hardman and Makarov reported the Orbital mass spectrometry 
coupled with an electrospray ionization source.7  
 
 
Figure 2.2 Orbitrap system 
 
2.3 Nuclear Magnetic Resonance 
 
Nuclear Magnetic Resonance (NMR) spectroscopy is a powerful analytical 
tool used to determine the structure of the isolated secondary metabolites in a 
non-destructive way. The nuclei of many elemental isotopes are characterized by 
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a specific number of spin (I). A spinning charge can generate a magnetic field, 
creating a spin-magnet with a magnetic moment (μ) proportional to the spin. 
Applying an external magnetic field (B0), it is possible to create different spin states 
of a nucleus, depending on the value of I (this number is equal to 2I+1) with different 
energy; this difference depends on the applied magnetic field strength. Nuclei with 
I=0 are known as “NMR inactive”, because they are not equipped with the nuclear 
spin property, essential to allow an NMR analysis. Hydrogen (1H), carbon (13C), 
fluorine (19F) and phosphorus (31P) represent nuclei possessing I=1/2, that means they 
can be analyzed using NMR. If nuclei with I≠0 are placed in a magnetic field, they 
will assume a possible number of different orientations that will correspond to 
specific energy levels; this number depends on the value of I, in particular, it is equal 
to 2I+1. 
When an external magnetic field is applied to nuclei with I= ½, they can assume two 
possible orientations, α parallel (I = ½), corresponding to the lower level of energy, 
or β antiparallel (I = - ½), corresponding to the higher level. The difference of energy 
is equal to: 
 
∆E = γ B0 
 
γ represents the gyromagnetic ratio, that is specific for certain nuclei. The protons are 
distributed between the two levels (α and β), with an excess of protons population in 
the α state, with its lower energy.8 
When an energy is applied (a radio frequency pulse), the nuclei undertake transitions 
from lower to higher energy levels; once the radiofrequency is switched off, is 
possible to observe the Free Induction Decay (FID), which is converted in the 
frequency domain, applying the Fourier Transform (FT). 
To carry out my research work, 1D and 2D NMR experiments have been widely used 
for structural elucidation of new natural compounds.  
COSY (COrrelation SpectroscopY) is a homonuclear chemical shift correlation 
experiment, based on the transfer polarization between spins that are directly J-
coupled. It is useful to establish the connectivity of a molecule by determining which 
protons are spin-spin coupled. 
HSQC (Heteronuclear Single Quantum Correlation) experiment is a heteronuclear 
correlation technique, in which only one-bond proton-carbon couplings (1JCH) are 
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revealed. Through the HSQC experiment is possible to correlate the chemical shift 
of a proton with the chemical shift of the directly bonded carbon.  
HMBC (Heteronuclear Multiple Bond Correlation) is a heteronuclear correlation 
experiment able to detect correlations between protons and carbons separated by two, 
three and, in the case of conjugated systems, four bonds; cross peaks between protons 
and carbons directly bonded are suppressed. This experiment is essential to obtain 
the connection of the fragments revealed through COSY and HSQC experiments, in 
order to unambiguously define the structure of the new natural products.9 
 
2.4 Determination of stereochemistry 
 
The determination of the absolute and relative configuration of a new natural 
compound is a crucial phase in the structure elucidation process, given the close 
relationship between the spatial arrangement of atoms in a molecule and the 
biological activity.  
Many natural products possess one or more chiral centers; a useful tool to establish 
their relative configuration is based on the analysis of NMR experiments, in 
particular through the evaluation of coupling constants (J), chemical shifts (δ), and 
NOE effects.  
 
2.4.1 Determination of relative configuration 
 
The proton chemical shifts of two diastereomers are different because they 
have diverse chemical milieu. The Karplus equation correlates 3J coupling 
constants and dihedral torsion angles  
 
3J= Acosθ2 + Bcosθ + C 
 
where 3J coupling constant indicates the correlation between two vicinal hydrogen 
atoms, θ is the dihedral angle, and A, B, and C are empiric parameters based on the 
substituents involved. The value of the coupling constant is the smallest when the 
torsion angle is close to 90° and largest when the angles are between 0° and 180°. 
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Using the Karplus equation is possible to have some preliminary informations about 
the relative atomic spatial arrangement of a molecule. 
NOESY (Nuclear Overhauser Enhancement SpectroscopY) is a useful NMR-based 
method to assign the relative configuration of stereogenic centers; the NOE effect 
can be detected after irradiation on a specific NMR signal, during the acquisition of 
the spectra: as a result, the relaxation times of all the protons close to the irradiated 
center (distance < 2.5 A°) change, including even those protons not belonging to the 
same spin system. In fact, the NOE effect occurs through space, not through chemical 
bonds; thus, atoms that are in proximity to each other can give NOE. 
ROESY (Rotating-frame Overhauser SpectroscopY) experiment is based on a 
chemical shift homonuclear correlation, as well as NOESY, which can detect ROE 
(Rotating-frame Overhauser Effect). This method is used for molecules with a 
molecular weight around 1000 daltons, for which the NOE is too weak to be 
observed.10 
 
2.4.1.1 Murata’s Method 
 
Murata et al.11 have reported a method for the assignment of relative 
configuration of acyclic compounds based on the combined use of homonuclear 
proton-proton coupling constants 3JH-H, heteronuclear proton-carbon coupling 
constants 2,3JH-C and NOE data. This model is basically applied to acyclic molecules 
presenting stereogenic carbons bearing hydroxyl, alkoxy or methyl substituents. 
Every chiral molecule containing streochemical centers can be ideally divided in two 
carbon fragments. This simplification allows to determine, for each single fragment, 
the predominant rotamer with the exact configuration, among all the possible 
staggered conformers by using a J-based NMR approach, see Scheme 2.1. It is 
possible to compare every single couple of vicinal asymmetric carbons to those 
belonging to a 2,3-disubstituted butane system, which could have two relative 
diastereomeric configurations, named syn (or threo) and anti (or erythro). Each of 
these two configurations can be arranged in three staggered rotamers, for a total of 
six possible conformers, as shown in Scheme 2.1 (A1, A2, A3, B1, B2, B3). Every 
single rotamer shows its own homonuclear and heteronuclear coupling constant 
pattern; thus, 3JH-H and 
2,3JC-H lead to unambiguously identify four of the six rotamers, 
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namely A1, A3, B1, B3. The two rotamers A2 and B2, characterized by an anti 
position of the two vicinal protons, can be distinguished on the basis of NOE (or 
ROE) data, because they show the same coupling constant pattern.  
The first step to determine the relative configuration of two vicinal methines involves 
the evaluation of homonuclear proton-proton coupling constant of the C2 fragment 
of interest. Small 3JH-H (0-4 Hz) indicate a gauche arrangement of H2 and H3 protons. 
In this case the relative configuration can be obtained from the heteronuclear 
coupling constants values. These 2,3JC-H values, indeed, allow to establish the 
arrangement (gauche or anti) of H2 and H3, leading to choose the correct gauche 
rotamer among A1, A3 (threo), B1 and B3 (erythro). Large 3JH-H values (8-12 Hz) 
indicate an anti disposition of the protons. Nevertheless, the 2,3JC-H values are the 
same for both rotamers A2 (threo) and B2 (erythro) (Scheme 2.1). In this case it is 
necessary to perform NOE experiments.  
 
 
 
 
Scheme 2.1 Identification of the single conformer with the correct configuration 
through the combined use of measured 3JH-H and 
2,3JC-H values. 
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2.4.2 Determination of absolute configuration 
 
2.4.2.1 Marfey’s Method 
 
The most widely used method to determinate the absolute stereochemistry of 
ribosomial amino acids is the Marfey’s method. This method consists of the 
derivatization of amino acid residues, obtained by complete acid hydrolysis of 
peptide, with a chiral agent FDAA (1-fluoro-2,4-dinitrophenyl-L-alaninamide, Fig. 
2.3), and then the comparison of retention times of these derivates from parent 
peptide with the retention time of appropriate standards D and L through HPLC.  
This method is enough easy for ribosomial amino acids, commercially available, and 
consist of four phases:  
a) hydrolysis of parent peptide with HCl 6 N;  
b) derivatization of the hydrolyzed mixture with L-FDAA;  
c) derivatization of both standards, D and L, with L-FDAA. It is possible to derivatize 
L-amino acid with D-FDAA, if the D-standard isn’t commercially available or is too 
expensive.  
d) analysis through HPLC of retention times.12  
 
 
 
Figure 2.3 Structure of L-FDAA 
 
2.4.2.2 Mosher’s Method 
 
Mosher’s method represents a valuable procedure to assign the correct absolute 
configuration to a chiral substrate by using NMR. It is based on the formation of a 
covalent bond between an unknown enantiomer and a chiral derivatizing agent 
(CDA); for our purposes α-methoxy-α-trifluoromethylphenylacetic acid (MTPA) has 
been used as a CDA. 
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The first step of the method consists in derivatizing the molecule, which possesses 
the unknown absolute configuration, with the two enantiomers of the MTPA 
separately, and comparing the NMR spectra of the two resulting diastereoisomers. 
The aryl ring present in the MTPA structure, causes different values of chemical 
shifts for the two substituents L1 and L2 present in the two MTPA derivatives (Fig. 
2.4), giving clear information about their spatial position.13 
 
 
Figure 2.4 Derivatization of the substrate with CDA 
 
After the subtraction of the chemical shift values for the two substituents L1 and L2 
of the (R)-MTPA derivative minus the values of the (S)-MTPA derivative, it is 
possible to create a tetrahedral model in which the substituent with the negative 
difference is placed in the front position, while the substituent with the positive 
difference is placed in the back position around the stereogenic carbon (Fig. 2.5).  
 
 
Figure 2.5 Assignment of configuration 
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2.4.2.3 Electronic circular dichroism 
 
When a molecule presents a chromophore in its structure, electronic circular 
dichroism (ECD) can be a successful method to determine the absolute configuration 
of the compound. Usually, the range used by UV-vis spectropolarimeters is between 
170–800 nm. An electronic transition can be associated to a positive or a negative 
ECD band, which is called a Cotton effect. 
ECD is a sensitive method that can be used with minute amounts of material. The 
interpretation of the obtained results is often carried out by a comparison between 
the experimentally obtained and computationally calculated ECD spectra (Fig. 2.6). 
 
 
Figure 2.6 ECD spectrum 
 
The first step of an ECD calculation is characterized by the conformational analysis 
of the molecule to obtain the relative energy evaluation of the possible conformers, 
while the second step provides the UV/ECD TDDFT (time-dependent density 
functional theory) calculation of each conformers. The UV/ECD spectra of the 
conformers are Boltzmann averaged, and then the calculated UV/ECD spectra of the 
isomers are performed. At this point, by comparison of the calculated ECD spectra 
with the experimental ECD of the natural product, the assignment of the absolute 
stereochemistry can be carried out.14 
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2.5 General Experimental Section for this PhD thesis 
 
Optical rotations (CHCl3) were measured at 589 nm on a JASCO P2000 
polarimeter. UV spectra were acquired on a Tecan Italia spectrophotometer and 
on an EL 311s automated microplate reader (Bio-Tek Instruments). ECD spectra 
were registered on a JASCO J-710 instrument. 1H (500 MHz) and 13C (125 MHz) 
NMR spectra were measured on a Varian INOVA NMR spectrometer. Chemical 
shifts are referenced to the residual solvent signal (CDCl3: δH 7.26, δC 77.0). 
Homonuclear 1H connectivities were determined by COSY experiments; one-
bond heteronuclear 1H−13C connectivities by the HSQC experiment; and two- 
and three-bond 1H−13C connectivities by gradient-HMBC experiments 
optimized for a 2,3J value of 8 Hz. Through-space 1H connectivities were obtained 
using a ROESY experiment with a mixing time of 500 ms. Low- and high-
resolution ESIMS were performed on an LTQ OrbitrapXL (Thermo Scientific) 
mass spectrometer. Medium-pressure liquid chromatography was performed on 
a Büchi (Switzerland) apparatus using a silica gel (7−230 mesh) column; 
separations were monitored by TLC on Merck 60 F254 (0.25 mm) plates and were 
visualized by UV inspection and/or staining with 5% H2SO4 in ethanol and 
heating. HPLC was conducted on a Knauer apparatus equipped with a refractive 
index detector. Luna (normal phase, SI60, 250 × 4 mm) (Phenomenex) columns 
were used, with 0.7 mL/min as flow rate. 
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CHAPTER 3: 
 
TRPA1 MODULATING C14 POLYACETYLENES FROM THE 
IRANIAN ENDEMIC PLANT ECHINOPHORA PLATYLOBA 
 
The first part of my Ph.D. thesis has been focused on the phytochemical 
investigation of the polyacetylene fraction obtained from Echinophora platyloba DC, 
an Iranian endemic plant belonging to the family Apiaceae, thank to a collaboration 
with Kermanshah University of Medical Sciences (Iran). The isolated compounds, 
characterized by the very rare α- pyrone moiety almost completely unprecedented in 
the structure of natural polyacetylenes, were evaluated for their modulation of six 
thermo-TRP channels. The results obtained have led to disclose a selective activity 
on TRPA1, an ion channel involved in the mediation of neuropathic and 
inflammatory pain.  
 
3.1 The Apiaceae family 
 
The Apiaceae (or Umbelliferae) family, one of the biggest families of flowering 
plants, includes 3780 species in more than 400 genera. It is worldwide distributed, 
mainly in the mild climate of northern regions, and a significant number of its 
members are endemic to Mediterranean area. Plants of the Apiaceae family are 
generally characterized by aromatic nature, alternate leaves, small flowers arranged 
in simple or compound umbel, and indehiscent fruits. As reported by a large number 
of studies found in the literature, these plants have been historically used in 
traditional medicine to treat gastrointestinal and neurological diseases, respiratory 
ailments, along with cardiac and urinary disorders. The broad variety of 
pharmacological activities displayed by the Apiaceae is due to their richness in 
secondary metabolites, such as polyacetylenes, terpenes, steroids, flavonoids, and 
coumarins, detected as its main constituents.1 Nowadays a significant number of 
Apiaceae family’s plants are used for seasoning, staining and as fragrance in the 
cosmetics industry. Several species represent a remarkable source of essential oils 
characterized by the presence of more than 800 different components belonging to 
diverse chemical classes with a great pharmaceutical interest.  
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The most representative and cultivated members of this family are: caraway (Carum 
carvi L.), cumin (Cuminum cyminum L.), parsley (Petroselinum crispum L.), 
coriander (Coriandrum sativum L.), fennel (Foeniculum vulgare Mill.), anise 
(Pimpinella anisum L.), dill (Anethum graveolens L.), and carrot (Daucus carota L.) 
(Fig. 3.1).2 
 
 
Figure 3.1 Illustrative picture containing the most representative members of 
Apiaceae family 
Coriander has been traditionally used as remedy to treat different ailments, such as 
digestive disorders, respiratory and urinary systems diseases, considering that it has 
diuretic, carminative, diaphoretic and stimulant activities; besides, coriander seeds 
are a spice widely used in the Mediterranean area. Interestingly, as proved by in vivo 
studies, coriander showed to possess the capacity to enhance the activity of enzymes 
that have a key role in the digestive process, both of pancreatic and intestinal origin. 
In Ayurvedic literature, the regular use of a coriander seed decoction was reported to 
have an effective hypolipidemic potential. Moreover, in Moroccan and Palestinian 
pharmacopeia the use of coriander as a traditional diuretic or to treat urinary 
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infections has been reported. In traditional Iranian medicine, coriander has a long 
history of medicinal use for preventing convulsions, anxiety and insomnia.3  
Cuminum cyminum L., is one of the oldest and economically important plant species, 
widely cultivated in Asia, Africa and Europe. Cumin seeds have retained their 
importance as culinary spices, and they have been used in folklore therapy in 
different geographical areas, to treat various health disorders and ailments, such as 
toothaches, epilepsy, dyspepsia, and jaundice. These pharmacological activities have 
generally been attributed to the rich content of active natural compounds, such as 
terpenes, phenols, and flavonoids.4-5 
Foeniculum vulgare, commonly known as fennel, is a medicinal and aromatic plant 
traditionally used as carminative, lactogogue, diuretic, and also to treat respiratory 
and gastrointestinal disorders. Phenols, phenolic glycosides and volatile metabolites, 
such as trans-anethole, fenchone, and estragole have been reported as the major 
secondary metabolites present in this species. Several in vitro and in vivo 
pharmacological studies have demonstrated the ability of F. vulgare to exhibit 
antifungal, antibacterial, antithrombotic and hepatoprotective activities, rationalizing 
several of its traditional uses.6 
Pimpinella is a genus comprising almost 150 species distributed in Europe, Asia and 
Africa; among the Pimpinella species, P. anisum is the most widespread member, 
which has long been used as a folk remedy against respiratory and gastrointestinal 
disorders. Seeds are determined as the most commonly used part of these plants. 
According to several pharmacological studies, Pimpinella species exhibited various 
pharmacological activities such as antimicrobial, anti-diabetic, anti-inflammatory, 
neuroprotective, and antiviral.7 
 
3.1.1 Echinophora genus 
 
Echinophora is a genus of the Apiaceae family (tribe Echinophoreae) widely 
distributed in the Mediterranean regions, from Spain to the Balkans, and the Middle 
East. These herbs are characterized by spiny leaves and yellow flowers, indeed their 
Latin name derives from echino = spine, phora = leaf, and their prefer to grow 
especially in sandy coastal areas. Due to the pleasant aromatic taste, some 
Echinophora species have found use as seasoning in the preparation of food or as a 
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flavoring agent for soups, meats, and dairy products.8 Fresh or dried herbs are also 
employed in the traditional medicine, not only for the well-known antimicrobial and 
antifungal activities, but also to treat gastric ulcers.9-10 Although a direct correlation 
between claimed biological activity and secondary metabolite content is still lacking, 
the Echinophora genus has been the object of intense phytochemical investigations 
that have disclosed the presence of saponins, flavonoids11 and polyacetylenes.12 
Among the about 20 Echinophora species described to date, only E. cinerea (Boiss.) 
Hedge et Lamond and E. platyloba DC are endemic to Iran (Fig. 3.2). 
 
 
Figure 3.2 Echinophora platyloba DC 
 
The Irano-Anatolian region, covering an area of about 899,773 km2, represents one 
of the three biodiversity hotspots present in the Middle East, which comprise 
different kinds of ecosystems, including deserts, oases, forests and savannas. The 
Irano-Anatolian area is a World Heritage Site, appreciated for its great biodiversity, 
with about 6000 plant species. In particular, Iran massively contribute to this richness 
because, given the innumerable natural habitats present in the region, it is 
characterized by many unique plants and centers of local endemism. More than 8000 
plant species are recognized throughout the country, of which about 2000 are 
endemic.13 Due to the remarkable source of diversity that occurs in the Iranian flora 
and in the frame of our research project aimed at discovering the medicinal potential 
of Iranian endemic plants, the aerial parts of E. platyloba DC, for which only 
fragmentary phytochemical characterization was available in the literature, were 
investigated.  
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E. platyloba is a perennial aromatic plant, called “Khousharizeh” or “Tigh Touragh” 
in Persian, and commonly used as an edible vegetable.14 The aerial parts and essential 
oils of the plant are also used by local people as anti-mold agent to preserve the 
quality of food and as folk remedy for several ailments, especially for its 
antispasmodic, diuretic, and antimicrobial activities.15-16 In the present chapter, I 
describe the isolation of polyacetylene derivatives (1–3) from E. platyloba, which 
includes the new secondary metabolite echinophorin D (1), along with coriolic acid 
(4) (Fig. 3.3). The isolated polyacetylenes were evaluated for their interaction with 
the transient receptor potential (TRP) channels of ankyrin type-1 (TRPA1), cation 
channels widely expressed in the oral and nasal cavity, which play an important role 
in the perception of nociceptive and inflammatory pain. 
 
 
 
 
 
 
 
Figure 3.3 The chemical structures of 1–4, isolated from E. platyloba. 
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3.2 Polyacetylenes from Apiaceae family and their biosynthesis 
 
Polyacetylenes are a class of molecules characterized by the presence of two or 
more carbon–carbon triple bonds in their structure. These compounds have been 
isolated from different natural sources, such as plants, marine organisms, fungi etc., 
proving to possess a wide range of pharmacological activities. Focusing on plants, 
polyacetylenes are common secondary metabolites that is possible to find in many 
food plants, especially among those belonging to the Apiaceae family. The most 
widespread polyacetylenes found in these plants are of the falcarinol-type, like 
falcarinol (5), falcarindiol-3-acetate (6), falcarindiol (7), and falcarinone (8) (Fig. 
3.4), that are the main compounds responsible for the bitter off-taste of carrots; in 
addition, these compounds showed cytotoxicity against leukemia and myeloma cell 
lines.17  
 
 
 
Figure 3.4 Falcarinol-type polyacetylenes 
 
From the essential oil of Selinum tenuifolium Wall., an aromatic plant native of the 
Himalayan region, several C9-polyynes were isolated (9-11);
18 interestingly, these 
structures, bearing a ketone function or a hydroxyl group, were known as synthetic 
compounds, but they have never been reported as natural products (Fig. 3.5).  
Other falcarindiol derivatives, such as notoethers (12-13) and notoincisol A (14), 
were isolated from Notopterygium incisium Ting, a plant used in Chinese traditional 
medicine to treat inflammatory diseases such as rheumatoid arthritis; moreover, these 
natural products showed also a promising agonistic activity for PPARγ activation.19 
The C34-tetraynic aldehyde aciphyll (15) obtained from Aciphylla scott-thomsonii 
Cockayne & Allan, a plant widespread in New Zealand, showed antifungal activity.20 
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Furthermore, polyacetylenic β-D-glucopyranosyl glycosides (16-17) were obtained 
from the aerial parts of Mediasia macrophylla (Regel ex Schmalh.) Pimenov, a 
medicinal plant traditionally used in Uzbekistan for its anti-inflammatory properties 
and as natural preservative.21 
 
 
 
 
Figure 3.5 Selected polyacetylenes from the Apiaceae family 
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It is important to underline that one of the isolated compounds (17) is the first natural 
polyacetylenic product characterized by the presence of an α-pyrone moiety. The 
same uncommon feature has been recently found in Echinophora cinerea and E. 
platyloba, the plant described in this chapter. 
Given the pharmacological potential of Apiaceae polyacetylenes, biosynthetic 
pathway leading to their formation in the natural source has been studied in detail. 
As outlined in Scheme 3.1, the starting building blocks for polyacetylenes production 
is represented by saturated fatty acids, produced by the head-to-tail addition of 
malonyl entities to a growing acyl chain. At this stage, two different hypothesis that 
explain the key step of a preexisting double bond oxidation to the triple one, have 
been proposed; the first one proposes desaturation through an iron-catalyzed 
dehydrogenation with molecular oxygen; the second hypothesis is based on the 
elimination reaction of an activated enol carboxylate intermediate. The two 
biosynthetic routes can provide three different intermediates, such as crepenynic, 
stearolic and tariric acids; these monoacetylenic intermediates are the substrates for 
several possible reactions, leading to the great chemical diversity of natural polyynes. 
In the Apiaceae family, the crepenynate pathway is predominant. 
Crepenynic acid results from oleic and linoleic acids; after modification of chain 
length and unsaturation reactions, additional alkyne moieties, usually conjugated, are 
introduced in the initial skeleton. Hence, several reactions are performed in order to 
generate polyynes decorated with hydroxyl, ketone and epoxide groups; hydroxyl 
function can be further derivatized to give esters or glycosylated compounds. As 
regards C17 polyacetylenes, or more generally polyacetylenes with an odd number of 
carbon atoms in their structure, they are formed by decarboxylation.17,22 
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Scheme 3.1 Biosynthesis of polyacetylenes in the Apiaceae family 
 
3.3 Polycetylenes from Echinophora platyloba 
 
Aerial parts of E. platyloba were collected in the area of Marivan, Iran, and were 
dried and extracted sequentially with n-hexane, dichloromethane and acetone. 
Repeated purifications of the dichlorometane fraction by column chromatography 
and HPLC led to the isolation of pure compounds 1-4. The structures of the known 
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echinophorins B (2) and A (3) were secured by comparison of their spectroscopic 
data with those available in the literature.23 The acetone fraction was found to contain 
the non-polyacetylene oxylipin coriolic acid (4):24 to our knowledge, this is the first 
report of coriolic acid from a plant of the Apiaceae family. 
 
 
 
Echinophorin D (1) was isolated as a brown oil with molecular formula C14H10O2, as 
deduced on the basis of HR-ESIMS data. The 1H NMR spectrum of 1 (Table 3.1) 
was very simple, showing two doublets at δH 6.20 (J = 9.2 Hz) and 6.07 (J = 6.8 Hz), 
and a double doublet at 7.28 (J = 9.2 and 6.8 Hz), two coupled methylenes between 
δH 2.65 and 2.75 and a methyl singlet resonating at δH 1.95. All these proton 
resonances were associated to those of the directly attached carbon atoms by means 
of the 2D NMR HSQC spectrum, thus disclosing the marked high-field resonance of 
the methyl carbon (δC 4.5). In agreement with the molecular formula, the 13C NMR 
spectrum of 1 showed the resonances of eight non-protonated carbons, two of which 
were coincident at δC 75.6. The α-pyrone ring was defined on the basis of the HMBC 
correlations H-2/C-1, H-3/C-5 and H-7/C-5 and on the basis of the comparison of 
H/C resonances with NMR data of echinophorins A and B.23 The assignment of the 
carbon resonances of the three conjugated triple bonds was achieved through 
inspection of the HMBC spectrum. In particular, the 2JC-H and 
3JC-H correlations of 
Me-14 (δH 1.95) to C-12 (δC 64.7) and C-13 (δC 75.6) and of H2-7 (δH 2.68) with C-
8 (δC 75.6) and C-9 (δC 67.3) led to the assignment of resonances for two of the three 
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triple bonds. Since weak peaks for longer correlations (namely 4JC-H) can be observed 
for proton-deficient molecules embedding extensively conjugated systems, we could 
complete the assignment of the carbon resonances of the acetylenic system taking 
advantage of the HMBC cross-peaks from Me-14 to C-11 (δC 61.5) and H2-7 to C-
10 (δC 59.2). Thus, the structure of 1 was unambiguously determined as the first 
polyacetylenic compound to include an α-pyrone system and three conjugated triple 
bonds. 
 
Table 3.1 1H and 13C NMR data of Echinophorin D (1) a 
 
Pos. δH, mult., J in Hz δC, mult. 
1 - 162.2, C 
2 6.20, d, J = 9.2 Hz 114.2, CH 
3 7.28, dd, J = 9.2, 6.8 Hz 143.4, CH 
4 6.07, d, J = 6.8 Hz 103.7, CH 
5 - 162.9, C 
6 2.71, m 32.4, CH2 
7 2.67, m 17.4, CH2 
8 - 75.6, C 
9 - 67.3, C 
10 - 59.2, C 
11 - 61.5, C 
12 - 64.7, C 
13 - 75.6, C 
14 1.95, s 4.5, CH3 
 
a Spectra registered in CDCl3 
3.4 Activity on transient receptor potential ion channels 
 
Transient receptor potential (TRP) ion channels represent one of the most 
important class of calcium-permeable channels, first discovered in mutant 
Drosophila that, when exposed to intense light, showed transient calcium influx into 
photoreceptor cells; this is the explanation why the mutant gene was defined as 
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‘transient receptor potential’. TRP channels, with their six trans-membrane (TM) 
domains, comprise a large family of channel proteins, expressed in vertebrates and 
invertebrates, subdivided into six subfamilies: TRPV (vanilloid), TRPC (canonical), 
TRPM (melastatin), TRPML (mucolipin), TRPP (polycystin), and TRPA (ankyrin), 
differing in their primary amino acid sequences. 25 
TRP channels not only play a key role in physiological processes, such as signal 
transmission, but they can be defined as cellular sensors involved in nociception, 
thermosensation, and taste perception. Many diseases are related to dysfunction of 
these channels, including chronic pain, diabetes, obesity, chronic obstructive 
pulmonary disease, cancer etc. Notably, TRP channels are important targets for 
several natural products with therapeutic potential.26 For instance, capsaicin or 
menthol are able to activate the heat-sensitive TRPV1 and the cold-sensitive TRPM8 
channels, referring to them as not only temperature sensors but also chemosensory 
channels. Moreover, TRPV1 mediates excitation and subsequent desensitization to a 
naturally occurring compound called resiniferatoxin, found in Euphorbia resinifera 
and representing a more potent analog of capsaicin; resiniferatoxin is currently 
undergoing clinical trials to achieve permanent analgesia in the event of intractable 
cancer pain. Furthermore, TRPC6 is related in mediating the mood-improving effect 
of hyperforin, the main compound present in plants of the Hypericum genus. In 
summary, there are clear experimental and clinical data to define TRP channels as 
appealing drug targets, and several compounds targeting these channels are 
undergoing clinical trials, demonstrating that the discovery and development on new 
leads in this field is of great significance.27 
The Transient Receptor Potential Ankyrin 1 (TRPA1) is a channel characterized by 
the presence of 17 ankyrin-repeats and a calcium binding site in its N-terminus, along 
with a zinc binding site in the C-terminus (Fig. 3.6). It can be defined as a pain sensor, 
because it is mainly expressed in sensory neurons (where it is coexpressed with 
TRPV1), but recent works outlined that functional TRPA1 is also present in non-
neuronal tissues such as heart, lung, small intestine, and pancreas. Many studies 
carried out using TRPA1 knock-out mice and specific antagonists, have related the 
function of TRPA1 to the regulation of temperature perception, inflammation, and 
pain.28 It is activated by many irritant natural products, including allyl isothiocyanate, 
cinnamaldehyde and allicin, contained in mustard oil, cinnamon and garlic 
respectively, or by environmental irritants, such as acrolein or formalin. TRPA1 is 
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also activated by the non-pungent capsaicin analogue, capsiate, and by the non-
psychotropic cannabinoid, cannabichromene. This is remarkable because 
cannabichromene is considered to play a critical role in the anti-inflammatory and 
analgesic activity of cannabis extracts. In general, reactive chemicals activate TRPA1 
by inducing covalent modification of cysteines in the N-terminus. To date, only two 
TRPA1 antagonists designed to treat chronic and acute surgical pain have reached 
clinical stage of development. 
 
 
Figure 3.6 TRPA1 channel 
 
The activation of TRPA1 at nerve terminals results in membrane depolarization, 
mainly due to Na+ influx, and induces a local calcium influx through the channel 
which further releases neuropeptides such as calcitonin gene-related peptide (CGRP), 
substance P, or neurokinin A, from large dense-core vesicles via Ca2+-dependent 
exocytosis. The presence of neuropeptides causes a further amplification of 
nociception, recruitment of immune cells, vasodilatation and neurogenic 
inflammation. Accordingly, TRPA1 has been functionally linked to a number of 
chronic pain conditions associated with inflammation, including arthritic and cancer 
pain.29 From these informations it is possible to conclude that new TRP modulators 
are needed as viable candidates for drug discovery, and in this frame, natural product 
ligands are still intensely investigated as leads for TRP channels deorphanization. 
Natural products have a long history as TRP ligands, and many TRP channels are 
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activated/antagonized by secondary metabolites; for instance, it has been recently 
reported by our group the identification of some TRPA1 ligands from natural sources, 
e.g., curcumin30 and leucettamols,31 and two-headed sphingoid-like compounds. In 
the frame of this research project, the three polyacetylenic compounds from E. 
platyloba 1-3 have been evaluated by Dr. Luciano De Petrocellis (CNR, Pozzuoli, 
Italy) against six thermo-TRP channels (TRPA1, TRPV1, TRPV2, TRPV3, TRPV4, 
TRPM8) of great biomedical relevance. Coriolic acid (4) was not evaluated due to 
the small amount available. While the overall activity on the remaining TRPs was 
negligible, we found that the three compounds were able to modulate TRPA1 
(detailed results are reported in Table 3.2). Using a fluorimetric test, we observed 
that rat TRPA1-HEK293 cells exhibited an increase in intracellular [Ca2+]i upon 
application of 1–3. All compounds showed a discrete potency in the range 20–30 μM 
with echinophorin D, bearing three conjugated triple bonds, being the less potent 
compound of the series, and the two analogues showing two triple bonds exhibited 
an activity of almost the same magnitude. The activity of the compounds was 
normalised to the maximum intracellular Ca2+ elevation generated by application of 
allylisothiocyanate (AITC) 100 μM. Echinophorins A (3) and B (2) were able to 
reach about 80% of the maximal response of AITC, while the less active 
echinophorin D (1) reached only about 52%. 
 
Table 3.2 Activity of compounds 1-3 on calcium influx in HEK293 cells transfected 
with rTRPA1 
Compounds                           Efficacy     Potency EC50 μM    IC50 inh TRPA1 μM (AITC 100 μM) 
Echinophorin D (1)       51.7±1.3          30.9±2.8                           87.0±1.5 
Echinophorin B (2)       82.0±2.8          25.0±3.0                           37.2±0.8 
Echinophorin A (3)       81.0±3.3          20.3±3.2                           45.7±3.5 
a % AITC (Allylisothiocyanate) at 100 μM, used as a control 
 
Although the results obtained in this investigation are preliminary, since they derive 
from a very limited panel of natural products, they appear nevertheless interesting 
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for a couple of reasons. Firstly, to the best of our knowledge, this is the first report 
describing the modulation of TRP channels by polycetylenic compounds. Secondly, 
what is also remarkable is the selectivity of echinophorins toward TRPA1, an 
endpoint of relevance for treatment of inflammation and pain. Several polyacetylenic 
compounds have shown anti-inflammatory effects, mainly related to inhibition of 
NF-kB or to the modulation of prostaglandin catabolism.32 Our results suggest that 
modulation of TRPA1 could be another anti-inflammatory mechanism of 
polyacetylenes worthy of being explored. 
 
3.5 Experimental section 
 
3.5.1 Plant material, extraction and isolation 
 
The aerial parts of E. platyloba were collected in May 2010 on Mount Abidar, 
Marivan, Iran. The species was identified by Dr. Sayed Mohammad Masoumi, Razi 
University, and compared to the herbarium sample No. RUH585, Hamedan 
Herbarium, Iran. Aerial parts of E. platyloba (dry weight, 456 g) were extracted 
subsequently with n-hexane, dichloromethane and acetone using Soxhlet apparatus, 
4 h for each. The hexane phase (4.85 g) was composed mainly of fats and fatty acids 
and was no further investigated. The dichloromethane extract (4.98 g) was dissolved 
in MeOH (60 mL) and stored at -20 °C for 2 days. Afterwards, it was filtered chilled 
and the filtrate was fractionated by gravity column on RP18 stationary phase, using 
a solvent gradient from MeOH/H2O 1:1 to MeOH to obtain six fractions. The fraction 
eluted with MeOH/H2O 7:3 (62.0 mg) contained polyacetylenes, by 
13C NMR of the 
crude fraction, and was therefore separated by HPLC (n-hexane/EtOAc 1:1, flow rate 
0.7 mL/min) to afford pure echinophorin B (2, 5.1 mg), echinophorin A (3, 1.3 mg) 
and echinophorin D (1, 24.3 mg). The acetone extract (4.75 g) was fractionated by 
gravity column on silica gel using a gradient of heptane/EtOAc of increasing polarity 
(from heptane/EtOAc 9:1 to 1:1) to get eight fractions. The fraction eluted with 
heptane/EtOAc 7:3 (150 mg) was purified by HPLC (n-hexane/EtOAc 7:3, flow rate 
0.8 mL/min) to yield coriolic acid (4, 0.8 mg). 
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3.5.2 Spectroscopic data for the isolated compound 
 
Echinophorin D (1): Brown oil. 1H NMR (500 MHz): Table 1; 13C NMR (125 
MHz): Table 1. ESI-MS (positive ions): m/z 233 [M + Na] +; HRESI-MS: found m/z 
233.0583, C14H10O2Na requires 233.0578. 
3.5.3 Thermo TRPs Receptor Assays 
 
HEK-293 cells stably over-expressing recombinant rat TRPA1, TRPM8, 
TRPV2-4, TRPM8 or human TRPV1 were selected by Geneticin 600 μg mL-1, grown 
on 100-mm diameter Petri dishes as monolayers in minimum essential medium 
supplemented with non-essential amino acids, 10% fetal bovine serum, and 2 mM 
glutamine, and maintained under 5% CO2 at 37 °C. Stable expression of each channel 
was checked by quantitative real time-PCR. The effect of the substances on 
intracellular Ca2+ concentration [Ca2+]i was determined using Fluo-4, a selective 
intracellular fluorescent probe for Ca2+. Toward this aim, on the day of the 
experiment, cells over-expressing the TRP channels were loaded for 1 h in the dark 
at room temperature with the methyl ester Fluo4-AM (4 μM in DMSO containing 
0.02% Pluronic F-127, Invitrogen, Carlsbad, CA, USA) in minimum essential 
medium without fetal bovine serum. After the loading, cells were washed twice in 
Tyrode’s buffer (145 mM NaCl, 2.5 mM KCl, 1.5 mM CaCl2, 1.2 mM MgCl2, 10 
mM D-glucose, and 10 mM HEPES, pH 7.4), re-suspended in Tyrode’s buffer, and 
transferred (about 100,000 cells) to the quartz cuvette of the spectrofluorimeter 
(Perkin-Elmer LS50B; PerkinElmer Life and Analytical Sciences, Waltham, MA, 
USA) under continuous stirring. [Ca2+]i was determined before and after the addition 
of various concentrations of test compounds by measuring cell fluorescence at 25 °C 
(λEX = 488 nm, λEM = 516 nm). Curve fitting (sigmoidal dose-response variable slope) 
and parameter estimation were performed with GraphPad Prism® (GraphPad 
Software Inc., San Diego, CA, USA). Potency was expressed as the concentration of 
test substances exerting a half-maximal agonist effect (i.e., half-maximal increases 
in [Ca2+]i (EC50), calculated by using GraphPad®. The efficacy of the agonists was 
first determined by normalizing their effect to the maximum Ca2+ influx effect on 
[Ca2+]i observed with application of 4 μM ionomycin (Sigma, St. Louis, MO, USA). 
The increases in fluorescence in wild-type HEK293 cells (i.e., not transfected with 
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any construct) were used as baseline and subtracted from the values obtained from 
transfected cells. The effects of TRPA1 agonists are expressed as a percentage of the 
effect obtained with 100 μM allyl isothiocyanate (AITC). Antagonist/desensitizing 
behavior was evaluated for TRPA1 by adding the test compounds in the quartz 
cuvette 5 min before stimulation of cells with the agonist AITC (100 μM). Data are 
expressed as the concentration exerting a half maximal inhibition of agonist-induced 
[Ca2+]i elevation (IC50), which was calculated again using GraphPad Prism® 
software. The effect on [Ca2+]i exerted by agonist alone was taken as 100%. Dose-
response curves were fitted by a sigmoidal regression with variable slope. All 
determinations were at least performed in triplicate. Statistical analysis of the data 
was performed by analysis of variance at each point using ANOVA followed by 
Bonferroni’s test. 
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CHAPTER 4: 
 
PLASMODIUM TRANSMISSION BLOCKING AND 
ANTIPROLIFERATIVE METABOLITES FROM DAUCUS 
VIRGATUS, A TUNISIAN ENDEMIC PLANT 
 
The main part of my Ph.D. thesis involved the phytochemical investigation of 
the apolar extract obtained from a Tunisian endemic plant, Daucus virgatus, 
belonging to the Apiaceae family. Among the 80 species of Daucus genus, eleven 
species and seven subspecies are widespread in Tunisia, and they have been used in 
the traditional Tunisian medicine for their diuretic properties or as a remedy for the 
treatment of cutaneous infections. 
Daucus virgatus (Poir.) Maire, syn. Caucalis virgata Poir., Ctenodaucus virgatus 
(Poir.) Pomel, grows as an herbaceous annual or biennial species. It has slender, 
erect, decumbent and rigid stems of 30-70 cm; umbels are short and pedunculated 
with small pink or white colored flowers (Fig. 4.1).1 
After an initial screening of a library of plant extracts obtained from organisms 
belonging to the Tunisian flora, we selected Daucus virgatus for further 
investigation. The bio-guided analysis of the CH2Cl2 extract of D. virgatus revealed 
the presence of some fractions that showed a preliminary Plasmodium transmission-
blocking activity, which deserved further investigation in order to obtain the 
structural elucidation of secondary metabolites responsible for the pharmacological 
results. Following these leads, eight new angeloylated germacranolides have been 
isolated from the antimalarial fractions. 
Furthermore, the complete phytochemical characterization of the extract was 
performed, because interestingly, no data appear to be available in the literature about 
the composition of D. virgatus. Thus, considering the contribution of my research 
group to the biological and chemical profile of medicinal plants growing in Tunisia, 
the study of the chemical composition of this endemic plant seemed to be an 
appealing project.2-4 Hence, the additional isolated compounds, belonging to 
different families of molecules, were evaluated for their antiproliferative activity. 
The entire project has been carried out in collaboration with University of Monastir 
(Tunisia) for the plants’ collection, with University of Camerino (Italy) for the 
determination of the antimalarial pharmacological potential, and with University of 
Naples “Federico II” for the evaluation of the antiproliferative activity. 
  
 
45 
 
  
    Plasmodium transmission blocking and antiproliferative metabolites from D. virgatus  Chapter 4 
 
 
 
Figure 4.1 Daucus virgatus collected in the North of Tunisia 
 
4.1 Daucus genus  
 
The genus Daucus includes more than 80 accepted species, distributed mostly in 
Europe, North Africa, West Asia and only few in North America and Australia. The 
phytochemistry of the genus has been well studied, leading to determine the 
composition of several extracts of its members.1 Thus, the presence of flavonoids, 
polyacetylenes, terpenes and coumarins (Fig. 4.2) was detected and reported in 
studies mainly focused on various subspecies of Daucus carota, along with less 
common Daucus species, such as Daucus syrticus Murb, Daucus reboudii Coss., 
Daucus glaber Forsk., and Daucus gingidium L. 
The best-known member of the genus is certainly Daucus carota L., whose fruits are 
called “nanheshi” in China, and traditionally used for their diuretic, antibacterial, 
anthelmintic, antifungal and cytotoxic properties. Carrot has been spread in the 
Northern Mediterranean regions by the Arab invaders, and they also introduced 
several cultivars, such as yellow, purple, and red carrot. The color of the root is an 
indication of the nature of compounds present in different species; for example, red 
and yellow carrots mainly contain lutein and lycopene, while orange carrots are 
characterized by the presence of α- and β-carotene. Black carrots present large 
amounts of flavonoids, such as luteolin, quercetin, myricetin, kaempferol, and 
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chlorogenic acid, along with several anthocyanins, which have been shown a 
protective role against cancer, diabetes, and oxidative stress.5 
The Apiaceae family is rich in polyacetylene derivatives (See Chapter 3). In 
particular, the most abundant compound present in Daucus species is falcarindiol, 
followed by falcarinol, and falcarindiol-3-acetate. As shown by recent in vitro and in 
vivo studies, aliphatic C17-polyacetylenes of the falcarinol-type found in Daucus 
genus, exerted an interesting cytotoxic and chemopreventive activity; falcarinol, 
panaxydol, and panaxytriol, for example, were reported to possess high cytotoxic 
activity against leukemia (L-1210), mouse melanoma (B-16), mouse fibroblast-
derived tumor (L-929), and human gastric adenocarcinoma (MK-1) cells.6 Moreover, 
falcarinol has proved to be an antagonist of the cannabinoid CB1 receptor.7 
Monoterpenes are predominantly present in essential oils obtained from different 
Daucus species, with limonene, sabinene, and geraniol as three major products, along 
with α-thujene, α- and β-pinene, β-myrcene, and α-phellandrene.8  
Daucane-type sesquiterpenes, along with eudesmane and guaiane-type secondary 
metabolites, have been found in Daucus genus, and they have been shown mainly 
antibacterial and antiproliferative activities.9-10 
Coumarins, lactones of o-hydroxycinnamic acid, represent a broad class of 
allelochemicals, which are largely spread in almost all the higher plants. The 
presence of coumarins in the plant kingdom proves their important ecological role 
both in plant protection and in the communication with the external environment. 
The most important coumarins found in Daucus species are bergapten, 
isopimpinellin, and xanthotoxin, which are reported to have antibacterial and 
antifungal activities, along with immunosuppressive and anti-inflammatory 
properties.11 
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Figure 4.2 Secondary metabolites from Daucus genus 
 
4.2 Malaria: a still alarming global burden  
 
Malaria is an infectious disease transmitted by the bite of an infected female 
Anopheles mosquito and caused by several species of protozoan of the Plasmodium 
genus, four of which infect humans: Plasmodium falciparum, Plasmodium. vivax, 
Plasmodium malariae and Plasmodium ovale. It is endemic in more than 100 
developing countries and it continues to be one of the most alarming public health 
problems, especially in sub- Saharan Africa, in terms of global mortality and 
morbidity. The World Health Organization (WHO) estimated over 400 000 deaths 
and 212 million new infection cases in 2015, mainly among children under the age 
of five and pregnant women.12  
The Plasmodium life cycle (Fig. 4.3) begins after the release of the protozoan into 
the human’s bloodstream; indeed, during a blood meal, an infected female mosquito 
inoculates sporozoites into the human host. Sporozoites undergo an initial replication 
in the liver (exo-erythrocytic schizogony), where they mature into merozoites and 
invade erythrocytes, causing anaemia (erythrocytic schizogony); the rupture of 
infected erythrocytes leads to the release into the bloodstream of cell debris 
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responsible for the fever spike patterns associated to the symptoms of malaria. Thus, 
the clinical symptoms of the disease are entirely attributable to Plasmodium in the 
erythrocytic stage; in lethal cases, after a modification of the erythrocytic cell 
membrane caused by a protein produced by the parasite, the red blood cells can stick 
to the walls of brain capillaries causing obstruction, followed by unconsciousness 
and, if it is not immediately treated, it can lead to death. 
In some cases, merozoites can develop into male or female gametocytes, the sexual 
form of the parasite, which can be ingested by an Anopheles mosquito during a blood 
meal; the Plasmodium multiplication in the mosquito’s midgut is known as 
sporogonic cycle. The fusion of gametocytes results in diploid cells (zygote) and 
leads to ookinetes. After mitotic divisions, sporozoites are formed, and they migrate 
to the salivary glands, making the mosquito infective to humans.13 
Currently, the first-line treatment against malaria is represented by the Artemisinin-
based Combination Therapy (ACT), in which some artemisinin derivatives (Fig. 4.4) 
are used in combination with long-acting antimalarial with different mechanisms of 
action, along with the diffusion of vector control measures, such as indoor residual 
spraying and insecticide-treated mosquito bed nets. Unfortunately, artemisinin-
resistant strains of P. falciparum have appeared in South-East Asia and in five 
countries of the Greater Mekong subregion, with strong indications of rapid spread.14 
 
 
Figure 4.3 Malaria life cycle 
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Hence, new highly efficacious antimalarial drugs are urgently required, especially 
because the main drugs used to treat malaria are limited to three class of compounds, 
such as artemisinin analogues, quinolines and antifolates. This means that the 
attention of the scientific community must be focused on the malaria burden, in order 
to enrich the available chemotherapeutic arsenal to treat the infection, and to avoid 
possible resurgences of the disease, reaching the ambitious goal set by the WHO in 
its Global Technical Strategy for Malaria of a 90% reduction of malaria mortality 
within 2030. 
Nowadays, the battle against malaria represents a terrible emergency, given the 
insurgence of insecticide-resistant vectors, drug resistance, and lack of an effective 
vaccine; it is therefore important to realize that a single intervention will not be 
enough to fulfill the WHO objective, and additional tools need to be developed and 
employed for malaria prevention and treatment.15 
Thus, an integrated elimination/control strategy has a strong need to complement 
drugs active against the asexual blood stages of the parasite with antimalarials able 
to kill also the nonpathogenic Plasmodium stages responsible for transmission. These 
include gametocytes, the sexual forms of the parasite circulating for several days in 
the human host’s bloodstream, but also the early sporogonic stages (ESS, namely, 
gametes, zygotes, ookinetes) developing in the Anopheles mosquito midgut after a 
gametocyte-containing blood meal. Primaquine and a few other 8-aminoquinolines 
are, among the drugs in use, the only ones able to target mature gametocytes in the 
human host. In this regard, the final aim of our research project is the design of an 
antimalarial combination therapy active against both the asexual and sexual stages of 
the parasite.16 Hence, for pursuing this goal, the screening of natural products has 
already revealed to be a successful approach, especially if we consider the discovery 
of artemisinin as a remarkable example (See Chapter 1).  
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Figure 4.4 Artemisinin and its apolar (artemether) and polar (artesunate) 
derivatives 
 
4.2.1 Plants traditionally used to treat malaria 
 
Traditional herbal medicines have been used to treat malaria worldwide for 
centuries. The first antimalarial drug, deriving from the plant kingdom, was the 
alkaloid quinine, extracted from the bark of several Cinchona (Rubiaceae) species. 
Infusions of the plant bark were used to treat human malaria and in some African 
countries they are still largely administered. Then, years later quinine was isolated, 
characterized, and then used as a starting point for the synthesis of two antimalarial 
drugs: chloroquine and mefloquine. More recently, after the diffusion of chloroquine-
resistant P. falciparum strains, another natural product, artemisinin (isolated from the 
Chinese plant Artemisia annua), has been successfully used to treat these difficult 
clinical cases.17-18  
In the last years, there has been a great interest in the search for new natural leads 
that potentially could be developed as new drugs for the treatment of malaria and 
other infectious diseases and, in this regard, there is the possibility to draw on a huge 
natural heritage. Given the large number of plants traditionally used for their 
antimalarial activity and the recent availability of robust and reproducible screening 
methods for antimalarial agents, the research work aiming at the development of new 
drugs is still on the rise. 
In addition to the historical plants mentioned above, some other species are also 
commonly used for malaria treatment in Africa, such as Azadirachta indica, Khaya 
senegalensis, and Vernonia amygdalina, to name a few of them. 
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Azadirachta indica, also known as “neem tree”, is a plant still used in many African 
countries against fever and malaria as a decoction of the leaves, stem bark and root.  
NeemAzal® is a commercial extract obtained from the seeds of Azadirachta indica, 
that has shown to inhibit the Plasmodium development in the vector; azadirachtin A, 
a limonoid isolated from this plant, represent the main compound responsible for the 
activity. Indeed, it has been shown to significantly inhibit the formation of flagellate 
microgametes (one of the sexual stages of Plasmodium), suggesting that 
microgametogenesis is the final target of NeemAzal® transmission-blocking 
activity.19 
All the species of the Khaya genus, also belonging to the Meliaceae family, are well-
known for their high-quality wood, which is resistant to insect and fungal attack; they 
grow especially in the savannah forests, mostly in the countries of Nigeria, Senegal, 
Sudan, Uganda, and Zaire. In particular, stem barks decoctions of Khaya 
senegalensis and Khaya grandifoliola, usually planted by roadsides for shade, are 
extensively used as antimalarial remedies.20  
In sub-Saharan countries, the leaves of Vernonia amygdalina Del. are used for the 
treatment and prevention of malaria, and the antiplasmodial activity of this plant, 
belonging to the Asteraceae family, has been proved by in vitro and in vivo studies.  
Different secondary metabolites responsible for the biological activity have been 
isolated and characterized, and among them, sesquiterpene lactones have been shown 
to be the most active compounds against P. falciparum blood stages. They include 
the highly oxygenated derivatives vernolide, vernodalol, vernodalinol, 
epivernodalol, vernodalin and vernomygdalin.21  
In the frame of our ongoing research work, leading to the discovery of new promising 
natural products with Plasmodium transmission-blocking activity, the 
ethnopharmacological approach can be only a starting point, but it cannot give 
unequivocal indications. In fact, as mentioned in the previous paragraph, the final 
target of our project is the discovery of new lead compounds able to target also the 
non-pathogenic stage of malaria life cycle, and not only the asexual erythrocytic 
phase responsible for the clinical symptoms of the disease, that is normally the target 
of the traditional natural remedies. For this reason, the recent availability of robust 
and reproducible screening methods for antimalarial transmission-blocking agents 
inspired us to screen extracts obtained from plants of the African flora in order to 
select lead compounds endowed with stage-specific, transmission-blocking activity. 
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The bio-guided approach used in this study has been resulted in the isolation of eight 
new angeloylated germacranolides from the aerial parts of the endemic Tunisian 
plant Daucus virgatus, making possible to enrich the chemical weapons suited to 
fight the dreaded battle against malaria.  
 
4.3 The biosynthesis of Daucus sesquiterpenes 
 
Isoprenoids represent one of the biggest classes of natural products known to 
date. All members of this group are characterized by a five-carbon isoprene building 
block, that can be linked by a head-to-head or a head-to-tail condensation reaction; 
the introduction of different functional groups such as aldehydes, peroxides, 
alcohols, ketones, esters, etc., results in several linear or cyclic compounds. These 
include members of mono-, sesqui-, di-, and triterpene families. After modifications, 
the isoprene building blocks lead to the formation of isoprenoids or, as they are also 
called, terpenoids, which are crucial for a large number of cellular processes, 
comprising transcription modifications, protein degradation, photosynthesis electron 
transport, intracellular signaling, and defense mechanisms.22 
Even though plant isoprenoids have been used for centuries for their pharmacological 
applications, flavor, and aroma, scarce information on their chemical structures and 
properties were available until the beginning of the 19th century. All isoprenoids are 
synthesized by the subsequent condensation of the five-carbon monomer isopentenyl 
diphosphate (IDP), formed starting from acetyl-CoA, to its isomer, dimethylallyl 
diphosphate (DMADP). The first intermediate that can be generated is geranyl 
diphosphate (GDP, C10), formed by the condensation of IDP with another unit of 
DMADP; as outlined in Scheme 4.1, GDP leads to monoterpenes (C10).  
Reaction with an additional unit of IDP results in farnesyl diphosphate (FDP, C15), 
the substrate for the sesquiterpenes (C15), and, the subsequent elongation by addition 
of a C5 moiety provides geranylgeranyl diphosphate (GGDP, C20), the precursor of 
the diterpene family (C20). The terpenoid diversity is due to the capacity of natural 
enzymes to synthesize multiple products from the same substrate, through a complex 
reaction cascade. In this way, it is possible to maximize the structural diversity of the 
products obtained from the natural source, using the fewest number of biosynthetic 
steps.23 Sesquiterpenes are natural products found in both terrestrial and marine 
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environment, that have proved to possess a broad variety of promising biological 
activities; in this paragraph, I will focus the attention on the biosynthesis of 
sesquiterpene skeletons present in Daucus species, namely daucane-, eudesmane-, 
elemane- and germacranolide-type compounds. From a biosynthetic point of view, 
germacrane sesquiterpenes directly derive from (E, E)-farnesyl pyrophosphate (FPP), 
which is formed by the condensation of DMADP with two units of IDP; an enzyme, 
farnesyl pyrophosphate synthase, catalyzes the reaction. In turn, FPP is subjected to 
an ionization reaction to give a reactive transoid farnesyl carbocation, which can 
readily react with the C10–C11 double bond, leading to the formation of the (E,E)-
germacradienyl cation (Scheme 4.2). 
 
 
 
Scheme 4.1 Biosynthetic pathways of terpenoids 
 
  
 
54 
 
  
    Plasmodium transmission blocking and antiproliferative metabolites from D. virgatus  Chapter 4 
The cyclization step is catalyzed by an FPP cyclase and it is important to note that 
this reaction leads to the creation of a new stereogenic center. At this point, the 
resulting germacrane represents the key intermediate for the biosynthesis of 
eudesmane, and elemane sesquiterpenes. Otherwise, the isomerization around C2–
C3 double bond can generate the cisoid nerolidyl cation, which after cyclization leads 
to the cycloheptenyl cation, the key intermediate in the formation of daucane 
sesquiterpenes.24 
Several studies reported in the literature indicate that Daucus genus is characterized 
by the presence of sesquiterpene lactones mainly belonging to the daucane type. 
Remarkably, the phytochemical investigation of the apolar extract of D. virgatus has 
proved to be dominated by germacranolides and related derivatives, proving that in 
this species is primarily expressed the biosynthetic pathway leading to the formation 
of the transoid farnesyl carbocation. 
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Scheme 4.2 Biosynthetic route for the sesquiterpene lactones from D. virgatus  
 
With regard to the conformational behavior of the germacrane core, it is important to 
underline that the highest percentage of known germacranes are characterized by the 
flexible (E,E)-cyclodeca-l (10),4-diene ring core, but (Z,Z)-, (Z,E)-, and (E,Z)-
germacranes are also present in nature (Fig. 4.5). The studies focused on the 
conformational features of germacranes, in particular, the (E,E)-germacranes, have 
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shown that the 10-membered ring can exist in four different conformations which 
can be indicated as UU, UD, DU, and DD. U (up) and D (down), indicate the 
orientation of the C (14) and C (15) methyl groups. These conformers are 
interconvertible by rotation of each double bond through the ring. The main part of 
the naturally occurring (E,E)-germacranolides studied, shows the UU conformation. 
In contrast, the DU and UD conformations seem to be typical for the melampolides 
and heliangolides. The occurrence of these different germacrane conformations plays 
an important role in the biosynthesis of other sesquiterpenes.25 
 
 
 
 
Figure 4.5 Different germacranes conformations  
 
As an example of the biosynthetic pathway of germacranolides, and to show the 
mechanism for the functionalization of the isopropyl side chain, the biosynthesis of 
the well-known costunolide, a naturally occurring sesquiterpene lactone, will be 
described. This biosynthetic mechanism was proposed by de Kraker et al., pointing 
out that C15 hydrocarbon germacrene A is formed by FPP cyclization, catalyzed by 
germacrene A synthase (GAS); after a three-step oxidation of the methyl group at 
C12, by the cytochrome P450 germacrene A oxidase (GAO), the formation of 
germacra-1(10),4,11(13)-trien-12-oic acid is carried out. In turn, the latter is 
hydroxylated by (+)-costunolide synthase (COS) into an unstable intermediate that 
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undergoes a non-enzymatic lactonization of C6 hydroxyl and C12 carboxylic group, 
affording costunolide (Scheme 4.3).26 
 
 
 
 
 
 
Scheme 4.3 Biosynthesis of costunolide 
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4.4 Isolation and structural elucidation of angeloylated germacranolides 
with Plasmodium transmission blocking activity 
 
The aerial parts of D. virgatus were collected during the flowering stage in the 
area of Bizserta, Northwest Tunisia, dried, pulverized, and extracted by maceration 
in methanol. The crude methanol extract, after removal of the solvent under vacuum, 
was dissolved in water and defatted by partitioning with n-hexane and then 
partitioned against dichloromethane and n-butanol. Repeated purifications of the 
CH2Cl2 fractions, showing Plasmodium transmission-blocking activity, by column 
chromatography and HPLC, afforded daucovirgolides A−H (1−8) in the pure form 
(Fig. 4.6). 
 
 
 
Figure 4.6 New angeloylated germacranolides from Daucus virgatus 
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The stereostructures of the isolated sesquiterpene lactones have been determined by 
a combination of MS, 1D and 2D NMR spectroscopy, chemical derivatization, and 
comparison of experimental electronic circular dichroism curves with TDDFT-
predicted data. These secondary metabolites were identified as angeloylated 
germacranolides differing in the oxidation pattern and the acylation of the 
sesquiterpenoid core. Interestingly, when only an acyl group is present in the 
molecule, it is always an angeloyl group linked to the C-6, while if two acyl groups 
are present, the angeloyl group is linked to the C-11, while the other acyl group 
consists in an epoxy-angeloyl group linked to the C-6.  
The molecular formula C20H28O6, indicating seven unsaturation degrees, was 
detected for daucovirgolide A (1) by HRESIMS. The 1H NMR spectrum of (1) 
(Table 4.1) showed the typical resonances of the angeloyl group (δH 6.11, qq, 1H; 
1.99, d, 3H; 1.81, s, 3H), three resonances in the mid-field region, a series of 
multiplets between δH 2.83 and 1.43, and three relatively deshielded methyl singlets 
at δH 1.73, 1.57, and 1.36. The 2D NMR HSQC experiment (see Table 4.2 for 13C 
NMR assignments) indicated the presence of a trisubstituted double bond (δH 5.24, 
δC 126.7) and of three oxymethines (δH 5.79, δC 68.8; δH 4.80, δC 75.8; δH 2.83, δC 
62.2), with the latter probably being part of an epoxide ring. 
The 2D 1H−1H COSY spectrum of compound (1) arranged all the multiplets of the 
sesquiterpenoid core within two fragments (Fig. 4.7), the first spanning from the 
oxymethine H-1 to H2-3 and the second one connecting H-5 to H2-9 and 
encompassing the two remaining oxymethines (C-6 and C-8) as well as a branching 
at C-7. These two fragments were connected on the basis of the HMBC cross-peaks 
of CH3-14 (δH 1.36) and CH3-15 (δH 1.73) as shown in Fig. 4.7, resulting into the 10-
membered carbocyclic ring typical of the germacrane skeleton. The third methyl 
group (δH 1.57) showed HMBC correlations with C-7, the oxygenated C-11 (δC 71.7), 
and the lactone carbonyl C-12 (δC 178.8).  
Finally, correlations of H-8 with C-12 and of H-6 with C-1′ indicated 
unambiguously the lactonization and angeloylation positions on the germacrane core. 
The presence of an epoxide ring at C-1/ C-10 was in agreement with the molecular 
formula and with the H/C resonances at these positions, thus clearly defining the 
planar structure of daucovirgolide A (1) 
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Figure 4.7 COSY (red bold line), key HMBC (black arrows), and 
ROESY (blue arrows) correlations detected for daucovirgolides A (1) 
 
 
The network of ROESY correlations reported in Fig. 4.7 was used to assign the 
relative configuration of the six asymmetric carbons of (1), resulting into a trans 
junction of the lactone ring. The geometries of the epoxide ring and the Δ4(5) and 
Δ2′(5′) double bonds were also determined on the basis of proximities deduced from 
the ROESY experiment. 
HRESIMS indicated that daucovirgolide B (2) possesses the same molecular formula 
of compound (1). Comparison of the 1H NMR spectra of these two molecules showed 
some parallelisms, demonstrating only a small shift of resonances and, in a few cases, 
a change of their multiplicities. As for (1), the COSY spectrum of compound (2) 
showed the proton multiplets arranged in two spin systems, but clearly indicated the 
presence of scalar coupling between the epoxide 
methine (H-5, δH 2.60) and the angeloylated oxymethine H-6 (δH 5.12), while, in 
turn, the sp2 methine at δH 5.35 was coupled to H2-2. Combined analysis of the HSQC 
and HMBC experiments confirmed that daucovirgolide B (2) is an isomer of (1), 
presenting inverted epoxide and double-bond positions. The HMBC fully supported 
this assumption, and, in addition, cross-peaks H-8/C-12 and H-6/C-1′confirmed the 
placement of lactone and angeloyl groups, respectively.  
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Table 4.1. 1H NMR Data (500 MHz) in CDCl3 of selected daucovirgolides 
 
 
 
 
The ROESY spectrum, besides confirming the relative arrangement at C-6, C-7, C-
8, and C-11, indicated the relative configuration of the epoxide ring (from cross-
peaks of CH3-15 with H-6 and H-7).  
Daucovirgolide C (3), C20H28O8 by HRESIMS, was identified as an analogue of (2) 
with an oxidative modification at the Δ1(10) double bond. Inspection of the 1H and 13C 
NMR spectra of (3), clearly indicated that the sp2 methine signal at C-1 of (2) was 
replaced by a hydroperoxy-bearing sp3 methine (δH 4.53, δC 85.2; −OOH δH 7.84), 
and the CH3-14 singlet of (2) had been replaced by an sp
2 methylene (δH 5.38 and 
5.45, δC 121.0). Detailed analysis of the 2D NMR spectra of (3) supported this 
inference and, accordingly, H/C resonances at the remaining positions were closely 
 
Daucovirgolide  
A (1) 
Daucovirgolide 
C (3) 
Daucovirgolide 
 D (4) 
Daucovirgolide 
G (7)  
δH, mult., J in  
Hz 
δH, mult., J in  
Hz 
δH, mult., J in 
Hz 
δH, mult., J in 
Hz 
1a 2.83, d, 11.0 4.53, m 2.23, m 4.98, d, 10.0 
1b - - 2.25, m - 
1-OOH - 7.84, s - - 
2a 1.43, m 2.17, m 1.84, m 2.20, m 
2b 2.06, m 2.17, m 2.03, m 2.41, m 
3a 2.23, overlapped 2.09, m  4.28, d, 8.4 2.07, overlapped 
3b 2.30, dd, 13.0, 5.2 1.22, m - 2.21, m 
5a 5.24, d, 6.3 2.83, d, 7.8 2.23, overlapped 4.80, overlapped 
5b - - 2.44, d, 5.4 - 
6 5.79, d, 6.3 5.12, d, 7.8 5.47, m 5.63, bs 
7 2.41, bs 2.41, bs 3.06, t, 10.7 2.75, bs 
8 4.80, bdd, 12.0, 6.0 4.94, m 5.17, d, 11.2 4.80, overlapped 
9a 2.11, m  2.51, m  5.35, d, 11.2 1.88, overlapped 
9b 2.22, m  3.06, dd, 13.4, 3.2  2.99, overlapped 
13 1.57, s 1.59, s 1.45, s 1.84, s 
14a 1.36, s 5.45, bs  1.70, s 1.73, s 
14b - 5.38, bs  - 
15a 1.73, s 1.42, s 4.84, s 1.60, s 
15b -  5.14, s - 
3' 6.11, qq, 7.3, 1.1 6.11, qq, 7.3, 1.1 6.11, qq, 7.3, 1.1 6.17, qq, 7.3, 1.1 
4' 1.99, d, 7.3 1.99, d, 7.3 1.98, d, 7.3 2.03, d, 7.3 
5' 1.81, bs 1.84, bs 1.91, bs 1.89, bs 
3'' - - - 2.98, q, 5.4 
4'' - - - 1.23, d, 5.4 
5'' - - - 1.45, s 
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comparable to analogous signals for (2). The ROESY spectrum of (3) confirmed the 
relative arrangement for positions C-4/C-5/C-6/C-7/C-8 and C-11 and indicated the 
relative configuration at C-1 (cross-peaks H- 1/H-7 and OOH-1/H-9α), thus defining 
the relative stereostructure of (3).  
The 1H NMR spectrum of daucovirgolide D (4) (C20H28O6 by HRESIMS) clearly 
suggested that this compound belongs to the daucovirgolide structural series, 
exhibiting the presence of an angeloyl moiety, an exomethylene group (δH 5.14 and 
4.84, both bs), and two methyl singlets at δH 1.45 and 1.70. Having associated all the 
proton signals to the directly linked carbon atoms by means of the HSQC spectrum, 
the proton multiplets were arranged into the two spin systems shown in Fig. 4.8. 
The 10-membered ring of the germacranolide system was assembled on the basis of 
the HMBC cross-peaks of CH3-14 and H2-15 (Fig. 4.8), while HMBC correlations 
of H-6 and H-8 with the ester carbonyls indicated the relative placement of the 
angeloyl moiety and of the lactone ring, respectively. Finally, HMBC correlations of 
CH3-13 with C-7, the oxygenated C-11, and the carbonyl C-12 completed the 
definition of the planar structure of daucovirgolide D (4). 
The relative configuration at C-6, C-7, C-8, and C-11 of (4) proved to be the same as 
that of 1−3, on the basis of the network of ROESY cross-peaks shown in Fig. 4.8. 
This configuration was connected to that at C-3 based on the marked ROESY 
correlation H-3/H-6, which indicated the β-orientation of the hydroxy group at C-3. 
 
 
 
Figure 4.8 COSY (red bold line), key HMBC (black arrows), and 
ROESY (blue arrows) correlations detected for daucovirgolides D (4). 
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The structures of the remaining daucovirgolides E−H (5−8) included two different 
acyl groups, identified readily as angeloyl and epoxyangeloyl units on the basis of 
their NMR spectroscopic data (see Tables 4.1 and 4.2). Interestingly, the 
epoxyangeloyl group was attached consistently at C-6 (HMBC cross-peak H-6/C-″
), while the angeloyl group was linked at C-11 in each case. The relative 
configuration of the epoxyangloyl group was inferred from the ROESY cross-peak 
between H-3″ and Me-5. It should be noted that, for all of compounds 5−8, the 
relative configuration at the epoxyangeloyl moiety could not be connected to that of 
stereogenic centers belonging to the germacrane ring. 
 
 
Table 4.2. 13C NMR data (125 MHz) in CDCl3 of selected daucovirgolides 
 
Pos. Daucovirgolide  
         A (1) 
Daucovirgolide  
C (3) 
Daucovirgolide 
 D (4) 
Daucovirgolide 
G (7)  
δC, mult.  δC, mult. δC, mult. δC, mult. 
1 62.2, CH 85.2, CH 39.1, CH2 131.5, CH 
2 24.3, CH2 25.7, CH2 34.5, CH2 24.4, CH2 
3 36.7, CH2 33.9, CH2 71.5, CH 38.4, CH2 
4 136.4, C 58.4, C 149.7, C 138.7, C 
5 126.7, CH 65.5, CH 40.6, CH2 126.0, CH, 
6 68.8, CH 68.8, CH 68.5, CH 70.6, CH 
7 51.4, CH 50.1, CH 50.6, CH 50.0, CH 
8 75.8, CH 78.7, CH 74.2, CH 79.0, CH 
9 42.6, CH2 40.1, CH2 118.4, CH 39.3, CH2 
10 57.1, C 139.8, C 146.7, C 138.2, C 
11 71.7, C 72.4, C 74.3, C 77.5, C 
12 178.8, C 177.9, C 179.0, C 174.0, C 
13 29.1, CH3 29.4, CH3 22.8, CH3 24.7, CH3 
14 22.1, CH3 121.0, CH2 17.3, CH3 20.7, CH3 
15 17.3, CH3 17.1, CH3 111.3, CH3 16.9, CH3 
1' 166.7, C 166.3, C 167.6, C 167.2, C 
2' 127.2, C 127.2, C 127.5, C 126.8, C 
3' 140.8, CH 140.6, CH 139.4, CH 140.7, CH 
4' 16.0, CH3 16.1, CH3 15.9, CH3 15.9, CH3 
5' 20.5, CH3 20.5, CH3 20.5, CH3 20.4, CH3 
1''    168.2, C 
2''    59.3, C 
3''    59.6, CH 
4''    13.2, CH3 
5''    18.4, CH3 
 
 
  
 
64 
 
  
    Plasmodium transmission blocking and antiproliferative metabolites from D. virgatus  Chapter 4 
Daucovirgolide E (5) was determined to possess the same 1,10-epoxygermacranolide 
core of (1) on the basis of a parallel pattern of H/C resonances (with the exception of 
those belonging to the γ-lactone ring) and 2D NMR correlations, including the 
ROESY spectrum. Similar reasoning was applied to assign the structure of 
daucovirgolide F (6), which was found to possess the same 4,5-epoxygermacranolide 
core as (2). 
Daucovirgolide G (7), C25H34O7 by HRESIMS, was identified as the likely 
biogenetic precursor of the daucovirgolides E (5) and F (6), since it shared 
epoxyangeloylation at C-6 and angeloylation at C-11 and included two trisubstituted 
double bonds at Δ1(10) and Δ4(5) (δH 4.98, δC 131.5; δH 4.80, δC 126.0, respectively). 
The ROESY cross-peaks CH3-14/H2-2 and H-5/H2-3 defined the E- geometry at both 
these centers. 
Finally, minute amounts of daucovirgolide H (8), C25H32O8 by HRESIMS, were also 
isolated. The additional unsaturation degree and the additional oxygen atom, when 
compared to (7), implied by this molecular formula, were rationalized by the 
presence of a ketone carbonyl (δC 204.1) at position 1, conjugated with the Δ10(14) 
exocyclic double bond. Accordingly, the deshielded sp2 methylene protons resonated 
at δH 5.88 (bs) and 6.06 (bs), and a marked downfield shift was also experienced by 
protons at C-2 (δH 3.36 and 2.28) and C-9. 
The stereostructure of the remaining part of the molecule was the same as that of 
daucovirgolide G (7). 
 
4.5 Absolute configuration of daucovirgolides 
 
Germacranes are an extremely diverse class of sesquiterpenoids, and their 
variability is not limited to their structural architecture; it also includes 
stereochemical features. For example, molecules containing a 1,5-cyclodecadienes 
moiety in their structure can exist in different conformers that are very close in 
energy, showing the possibility to be interchangeable, given the small energy 
barriers. Germacranolides are endowed with large conformational freedom, but this 
freedom is primarily restricted by the γ-lactone ring fused to the cyclodecadiene core. 
Four principal conformational forms have been proposed (Fig. 4.9). 
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Figure 4.9 Conformational equilibrium of germacranolides 
 
Following Samek’s nomenclature, these conformers are indicated as [15D5, 1D14] and 
[15D
5, 1D14], meaning that the two double bonds C1-C10 and C4-C5 are cross 
oriented, while the conformers [15D
5 ,1D
14] and [15D5, 
1D14] possess the double bonds 
in parallel position (Fig 4.9). The four conformers exist in a dynamic equilibrium 
through rotation of the bonds close to the C1-C10 and C4-C5 double bonds. For 
example, the stereostructure of the sesquiterpene lactone 6-
epidesacetyllaurenobiolide, a germacranolide isolated from Montanoa grandiflora, 
was determined by X-ray diffraction. The X-ray data clearly proved that the 10-
membered ring exists in a [15D
5 ,1D
14] conformation, showing that the methyl group 
at C-4 is α-oriented, while the methyl group at C-10 is β-oriented. Conversely, the 
common conformation [15D5,1D
14] of the costunolide-type germacranolides, display 
both methyl groups above the plane of the 10-membered ring (β-oriented).27 
Germacranolides related to daucovirgolides and belonging to two enantiomeric 
stereochemical series have been found in different plants; thus, an unambiguous 
experimental determination of absolute configuration for the isolated compounds 
appeared necessary. Analyzing daucovirgolide A (1), for example, a simple 
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derivatization with chiral auxiliaries was not applicable in this case, consequently a 
computational approach was applied. Thus, a molecular modeling analysis on 
compound (1) (with simulations carried out for 500 ps by using the CVFF force field 
as implemented in Discover software) afforded three reasonably populated 
conformers (Fig. 4.10). 
 
 
 
 
                    1a                                        1b                                        1c 
 
Figure 4.10 Structure of daucovirgolide A (1) and its three populated conformers 
 
 
The Boltzmann-averaged CD curves for the two enantiomers of (1) were calculated 
using the TDDFT approach, with Gaussian03 software, and then compared to the 
experimental data (Fig. 4.11), thus indicating the absolute configuration of 
daucovirgolide A.  
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Figure 4.11. Experimental ECD curve of daucovirgolide A (black) and calculated 
ECD curves for 1S,6S,7R,8S,10S,11S-1 (blue) and its enantiomer (red). 
 
 
Given the structural relationship between daucovirgolide A (1), B (2), and C (3), the 
absolute configuration could be assigned for all indicated compounds. 
The Mosher ester method was applied to determine the absolute configuration of 
daucovirgolide D (4), by making use of a secondary alcohol present in the structure 
of this metabolite.28 Thus, compound (4) was treated with R-(−)-and S-(+)-MTPA 
chloride to give the S-MTPA (4a) and R-MTPA (4b) ester, respectively (Fig. 4.12). 
Analysis of the Δδ(S−R) values, following the Mosher’s model, suggested the 
assignment of the S configuration at C-3 of (4). Given the above-determined relative 
arrangement, the absolute configuration of the entire molecule was assigned. 
Since the same absolute configuration was assigned for common stereogenic centers 
to two different daucovirgolides (1 and 4), by means of different methods 
(comparison of experimental and calculated ECD and Mosher derivatization), it can 
be reasonably assumed that all the members of this family of germacranolides belong 
to the same stereochemical series. 
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Figure 4.12 Application of the Mosher’s method to daucovirgolide D 
(4). Selected Δδ(S−R) values (in ppm) are shown. 
 
4.6 Plasmodium transmission-blocking activity 
 
The isolated germacranolides (with the exception of compounds (4) and (8), 
which were isolated in too minute amounts or needed for stereostructural 
determination) were investigated in vitro for inhibition of Plasmodium early 
sporogonic stages development, using the rodent malaria parasite P. berghei 
(CTRPp.GFP strain).29 Parasitized gametocytemic mouse blood was incubated in 
microtiter plates with daucovirgolides at a concentration of 50 μg/mL, and vernodalol 
was used as a positive control.21 The sesquiterpene lactone vernodalol (see Fig. 4.15) 
is an elemanolide isolated from the leaves of Vernonia amygdalina; as mentioned 
before (See paragraph 4.2.1), this plant is largely used to treat malaria infections in 
many African countries, and vernodalol showed to inhibit the in vitro ESS 
development by 70–90% at tested concentration (50 μM). Dose range experiments 
conducted with vernodalol allowed to determine an IC50 value of 18.7 µM.
21 Given 
this remarkable pharmacological result, vernodalol was chosen to be a positive 
control in our biological test for the evaluation of the Plasmodium transmission-
blocking activity of the isolated daucovirgolides. This test was carried out by the 
group of prof. A. Habluetzel at the University of Camerino (Italy). As illustrated in 
Fig. 4.13, daucovirgolide G (7) showed a marked inhibition (about 92%) of ESS 
development at the tested concentration, while all the others daucovirgolides 
exhibited moderate bioactivity, with inhibition percentages ranging from 22% to 
35%. Dose-range experiments and stage-specific impact assessment conducted with 
daucovirgolide G (7) permitted to determine the IC50 values, which were of 82.3 μM 
  
 
69 
 
  
    Plasmodium transmission blocking and antiproliferative metabolites from D. virgatus  Chapter 4 
(CI95 69.0−96.8 μM) on overall ESS development and of 48.4 μM (CI95 44.5−52.8 
μM) on the capacity of zygotes to undergo ookinete maturation. It should be noted 
that daucovirgolide G (7) proved to be noncytotoxic (IC50 > 100 μM) toward the 
HACAT (keratinocyte) and A375 (melanoma) cell lines, proving to possess an 
interestingly high bioactivity that deserve further investigation. 
 
 
 
Figure 4.13. Activity of daucovirgolides against P.bergehi CTRPp.GFP ESS 
expressed as percentage of ESS development. Vernodalol was used as positive and 
DMSO 0.1% as negative solvent control. Vertical bars indicate S.E.M. Results 
derive from two experimental replicates, testing the molecules in triplicate wells. 
 
 
Although numerically limited, the series of compounds tested was structurally 
homogeneous; thus, the selective activity of daucovirgolide G (7) points to the 
occurrence of strict structural requirements for the transmission-blocking activity. In 
fact, the presence of the epoxide group in place of one of the two double bonds, as in 
daucovirgolides E (5) and F (6), dramatically affected the activity, which also was 
not evident for the monoacylated analogues (1) and (2). 
Interestingly, a similar deleterious effect associated with the presence of the epoxide 
ring has been recently observed by Gertsch and co-workers for the potent 
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cannabinoid CB2 receptor agonism of β-caryophyllene; selective activation of the 
CB2 receptor could lead to the development of a potential therapeutic strategy for the 
treatment of inflammation, pain, osteoporosis, and atherosclerosis. Similarly to what 
has been observed for daucovirgolides, in the case of β-caryophyllene the activity is 
completely lost by caryophyllene monoepoxide (Fig. 4.14). This selectivity was 
rationalized on the basis of the existence of a crucial ligand-binding site π−π stacking 
interaction.30 Thus, the existence of a well-defined (although not yet identified) 
biological target within the Plasmodium cells of the early sporogonic stages can be 
postulated also for daucovirgolide G (7). 
 
 
 
 
Figure 4.14 Structures of β-caryophyllene and caryophyllene monoepoxide 
 
Daucovirgolide G becomes part of the small family of terpenoids active against 
Plasmodium transmissible stages, which includes azadirachtin A and vernodalol, 
whose transmission blocking activity was described before (See paragraph 4.2.1), 
along with parthenin, and parthenolide (Fig. 4.15). Parthenin is a sesquiterpene 
lactone isolated from Parthenium hysterophorus, an invasive weed that causes a 
significant decrease of the agricultural productivity because inhibit the growth of 
neighbouring plants, and it is also responsible for allergic contact dermatitis. Further 
studies have proved that these detrimental effects can be attributed to parthenin, a 
secondary metabolite produced by the plant. This compound has shown a broad 
variety of biological effects, including antiparasitic and anticancer activities, but the 
cytotoxicity of parthenin shall be considered as a negative side. Parthenolide is 
another compound that possesses properties similar to those of parthenin; it derives 
from Tanacetum parthenium and in contrast to parthenin, parthenolide is less 
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cytotoxic. A recent study has been demonstrated that both parthenin and parthenolide 
was able to inhibit the development of the stage V gametocytes of Plasmodium life 
cycle.31 Although daucovirgolide G (7) is less potent than the densely functionalized 
limonoid azadirachtin A, the strongly electrophilic vernodalol and then parthenin and 
parthenolide, it is also considerably less toxic, lacking general toxicity against both 
normal and tumor cell lines. Thus, studies addressed toward investigation of the 
mechanism of action and lead optimization could disclose the antimalarial potential 
of daucovirgolide G (7) and related germacranolides. The biological results presented 
in this study, provided a strong argument for further insights into the possibility to 
synthesize some germacranolides analogs as potential transmission-blocking drugs. 
In the next chapter, the synthetic studies performed towards the total synthesis of the 
most active angeloylated germacranolide isolated from Daucus virgatus will be 
reported. 
 
 
 
Figure 4.15 Structures of terpenoids active against Plasmodium transmissible 
stages  
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4.7 Antiproliferative metabolites from Daucus virgatus apolar extract 
 
Given the total lack of data about the phytochemical characterization of Daucus 
virgatus, our interest was directed to complete the study of the plant apolar extract. 
For this purpose, further purifications of CH2Cl2 phase, led to the isolation of three 
previously undescribed sesquiterpenoids, namely the daucane vaginatin B (14), a 
eudesmane (15) and the elemane elemavirgolide (16), along with five known 
metabolites. The isolated compounds were evaluated for antiproliferative activity 
against three human cell lines, A375 (melanoma), MCF-7 (breast adenocarcinoma), 
and HACAT (keratinocyte). 
 
 
4.7.1 Structural elucidation of the isolated metabolites 
 
After the isolation of secondary metabolites in their pure form, the structures of the 
known compounds (9-13) were assigned by comparison of their spectroscopic data 
with those reported in the literature,32-40 while the structures of the new natural 
products (14-16) were determined by a detailed MS and NMR analysis (Fig. 4.16). 
Compound (9) was identified as 6-methoxymellein, a dihydroisocoumarin involved 
in the defense mechanisms of plants, and believed to be responsible for the bitter 
taste of wild carrot (D. carota); although a recent work based on sensory and 
quantitative studies, has questioned this function.32 
Compound (10) is represented by matairesinol, a dibenzylbutyrolactone plant lignan, 
possessing several biological activities, such as antifungal, anti-oxidative and 
estrogenic ones. Additionally, a recent study showed the anti-inflammatory activity 
of matairesinol, which is able to decrease LPS-stimulated NO production, and the 
expression of pro-inflammatory mediators (iNOS and COX2) in the microglia. 
Moreover, it displayed to possess the capability to down-regulate NF-Κb activation.33 
Compound (11) was identified as the phenylpropanoid diester laserine oxide, first 
isolated from Laserpitium scabrum Cav., a pubescent perennial umbelliferous 
species.34 
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Figure 4.16 Chemical structures of antiproliferative metabolites isolated from 
Daucus virgatus 
 
 
Compound (12), 6-hydroxycamphor, constitutes a catabolic product deriving from 
(+)-camphor, a monoterpene present in large amount in the essential oil of Salvia 
officinalis; as well as other monoterpenes, (+)-camphor plays a key role in plant-plant 
or plant-insect interactions.35 
The last known compound is the daucane sesquiterpene vaginatin (13), first isolated 
from the roots of Selinum vaginatum, but later found also as antimicrobial metabolite 
in Ferula hermonis.36 As outlined in a recent work, vaginatin displayed a selective 
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activity as glucocorticoid receptor (GR) modulator, along with the capacity to inhibit 
AP-1, a pro-inflammatory factor.37 
Vaginatin B (14) was isolated as an optically active colorless oil. Its molecular 
formula, C25H36O6, determined by HR-ESIMS, indicated eight unsaturation degrees. 
Spectral data of (14) suggested that vaginatin B was a sesquiterpene bearing two C5 
acyl groups. In fact, NMR data of vaginatin B and vaginatin (13) were almost 
superimposable, but some relevant differences could be detected:38 
1) the deshielded methyl at δH 1.84 (H3-14) was replaced by a pair of doublets 
resonating at δH 4.57 and 4.51 (J = 13.2 Hz);  
2) the resonances of an additional angeloyl group were present, flanking those 
attributable to the acyl group attached at C-10.  
Inspection of 2D NMR COSY and HSQC spectra of (14) confirmed this assignment, 
displaying the presence of the same spin systems present in vaginatin. The HSQC 
spectrum associated the oxymethylene proton signals resonating in the midfield 
region of the 1H NMR spectrum to the carbon at δC 69.1. Finally, the HMBC 
spectrum confirmed the structure of vaginatin B, allowing the unambiguous linkage 
of the two angelate groups at C-10 (cross-peak H-10/C-1’) and C-14 (cross-peaks 
H2-14/C1’’), respectively. Since the 13C NMR resonances at the four stereogenic 
carbons of vaginatin B (14) were almost completely superimposable to those reported 
for (13) (δC values of (13) in ppm: C-1 = 60.1, C-4 = 50.8, C-5 = 82.3, C-10 = 75.5; 
δC values of (14) in ppm: C-1 = 60.2, C-4 = 51.0, C-5 = 82.6, C-10 = 75.1), we easily 
concluded that these two compounds possess the same relative configuration. Given 
the co-occurrence in the plant of vaginatins A (13) and B (14), we assume that the 
two compounds also share the same absolute configuration. 
Compound (15), C20H28O6 by HR-ESIMS, was isolated as a yellow-brown 
amorphous solid. The 1H NMR spectrum of (15) showed the typical signals of an 
angelate ester, along with three multiplets at relatively low fields (δH 5.42, 5.26 and 
4.84), an oxymethine signal at δH 3.60, a series of multiplets between δH 3.0 and 1.95, 
and three methyl singlets at δH 1.84, 1.47 and 1.01. The inspection of 2D NMR 
spectra (COSY, HSQC and HMBC) led to build up three spin systems, to join them 
and assign all the proton and carbon resonances. This allowed the definition of the 
structure of (15) as a C-8 angeloylated eudesmane bearing free hydroxyl groups at 
C-1 and C-11. A literature search displayed that this compound had already been 
reported by Appendino et al.,39 as a semisynthetic product obtained from 
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saponification reaction of the sesquiterpene lactone mixture extracted from 
Laserpitium gallicum (Apiaceae). Furthermore, eudesmane (15) had never been 
obtained before as a natural product.  
HR-ESIMS data indicated the molecular formula C20H28O5, implying seven degrees 
of unsaturation, for compound (16). 1H NMR spectrum showed a series of well 
resolved signals distributed in the regions between δH 6.15 and 4.80 (including six 
multiplets and two broad singlets), and between δH 2.85 and 1.07, including four 
multiplets and five methyl signals (a doublet and four singlets). The assignments of 
1H and 13C NMR resonances (CDCl3, Table 4.3) were assisted by COSY, HSQC, 
and HMBC spectra. In particular, inspection of the COSY spectrum allowed to 
combine the multiplet resonances of the 1H NMR spectrum into three spin systems 
(Fig. 4.17), next associated to their corresponding carbon atoms by the HSQC 
spectrum. The first fragment, connecting H-1 to H2-2, features a sp
2 methine (δC 
146.3; δH 5.83) coupled to a sp2 methylene C-2 (δC 112.3; δH 5.06 and 5.14), 
respectively. The second fragment, connecting H-5 to H2-9, comprised two 
oxymethines at C-6 (δC 78.5, δH 4.98) and C-8 (δC 67.0, δH 5.23) and a further 
branching at C-7. The third fragment included a methyl doublet coupled to a sp2 
methine and was clearly part of an angeloyl group, whose H/C resonances closely 
resembled those detected for compounds (14) and (15), including also the methyl 
singlet at δH 1.90. Three uncoupled methyl groups (δH 1.07, 1.49, 1.84) and a sp2 
methylene (δH 4.83 and 5.05, bs) completed the series of the proton signals, leaving 
only three unprotonated carbon atoms of the sesquiterpenoid core to assign. Analysis 
of the HMBC 2,3JC-H correlations connected the above proton spin systems (Fig. 
4.17). 
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Figure 4.17 Left: COSY (red) and HMBC (arrows) correlations of elemanolide 
(16); right: ROESY correlations 
 
 
 
Table 4.3 
1H (500 MHz) and 13C (125 MHz) NMR data of elemavirgolide (16) in CDCl3. 
 
Pos. δH, mult., J in Hz δC, mult. Pos. δH, mult., J in Hz δC, mult. 
1 5.83, dd, 17.5, 10.7  146.3 10  39.5 
2a 5.06, d, 10.7 112.3 11  75.1 
2b 5.14, d, 17.5  
 
12  177.6 
3a 5.05, bs 115.7 13 1.49, s 22.6 
3b 4.83, bs 
 
14 1.07, s 24.3 
4 
 
142.4 15 1.84, s 25.3 
5 2.36, d, 8.1 52.6 1’  167.0 
6 4.98, t, 8.1  78.5 2’  127.9 
7 2.86, t, 8.1  49.4 3’ 6.13, q, 7.2 139.7 
8 5.23, m 67.0 4’ 2.02, d, 7.2 16.4 
9a 2.02, overlapped 38.3 5’ 1.90, s 20.8 
9b 1.73, dd, 14.2, 8.1     
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Thus, the cross-peaks of Me-14 and Me-15 furnished a link between the first two 
fragments and defined the elemane nucleus; correlations of Me-13 to C-7, C-12 (δC 
177.6) and the oxygenated C-11 (δC 75.1), along with the cross-peak H-6/C-12 
indicated the presence of a γ-lactone group. Finally, the HMBC cross-peaks between 
H-8 and C-10 unambiguously attached the angeloyl group at C-8, allowing us to 
identify elemavirgolide (16) as an 8-angeloyl-11-hydroxy-elemanolide derivative. 
To our knowledge, elemavirgolide (16) is the first elemanolide to be reported from a 
Daucus species. The relative configuration of (16) was assigned on the basis of scalar 
(3JHH) and dipolar (ROESY correlations) couplings of the ring protons (Fig. 4.17). In 
particular, the values of JH-5/H-6, JH-6/H-7 and JH-7/ H-8 (all 8.1 Hz) was clearly indicative 
of trans-diaxial orientation of these protons. The ROESY cross-peaks H-5/H-7 Me-
14/H-6 and Me- 13/H-7, further confirmed the trans orientation of all the methines 
belonging to the six-membered ring and indicated the relative configurations at C-10 
and C-11, thus completing the definition of the relative stereostructure of 
elemavirgolide (16). Since a 5S, 10S configuration has been almost invariably 
associated to natural elemanolides, we can confidently extend this relative 
configuration to the absolute one.  
 
4.8 Antiproliferative activity 
 
All the isolated metabolites except vaginatin B (14), obtained in too minute 
amounts, were evaluated for their antiproliferative activity against A375 (human 
melanoma). In order to determine their selectivity, compounds were also tested 
against two additional human cell lines, MCF-7 (breast adenocarcinoma) and 
HACAT (keratinocyte). Results of this evaluation are reported in Table 4.4. 
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Table 4.4 
Antiproliferative activity of D. virgatus metabolites against A375, MCF-7, and 
HACAT cell lines. Results are expressed as IC50 (μM, means ± SEM). a  
 
Compounds                                      A375                      MCF-7                HACAT 
6-methoxymellein (9)                     77.3 ± 1.0               123.3 ± 0.5         131.2 ± 0.8 
Matairesinol (10)                             96.5 ± 0.8               117.1 ± 0.7         155.0 ± 1.0 
Laserine oxide (11)                          181.2 ± 0.6             227.9 ± 0.6         576.3 ± 0.8 
6-hydroxycamphor (12)                  207.1 ± 1.2             270.1 ± 0.9          367.0 ± 0.9 
Vaginatin (13)                                   126.0 ± 0.6            165.2 ± 0.7         273.4 ± 1.4 
Eudesmane (15)                                32.9 ± 0.6               213.0 ± 0.9        366.1 ± 0.6 
Elemavirgolide (16)                          197.0 ± 0.8            194.4 ± 0.3         646.0 ± 0.7 
a P < 0.001 vs. control. 
 
Among the isolated phenolic compounds (9-11), 6-methoxymellein (9) was the most 
active derivative, but it showed only a low selectivity for tumor cell lines. As 
mentioned, 6-methoxymellein is a phytoalexin produced by Daucus tissues in 
response to microbial invasions or after treatment with several elicitors,40 but 6-
methoxymellein has been demonstrated to be toxic also toward the producing plant 
cells, showing a higher potency compared to its precursor 6-hydroxymellein. To our 
knowledge, this is the first report about antiproliferative activity of (9) on human cell 
lines. It is also important to note that all the three tested sesquiterpenoids showed a 
remarkable higher antiproliferative activity against tumor cell lines compared to that 
against non-tumor keratinocytes, with a potency three times (in the case of 
elemavirgolide) and eleven times (in the case of eudesmane) higher. 
The selective activity on human melanoma showed by compound (15) opens the way 
to further investigation. In this regard, the skeletons of eudesmane (15) and 
elemavirgolide (16) differ only for some stereochemical details, but they almost 
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completely share the structures of rings B and C, including their substituents. This 
seems to outline that the structure of ring A, which includes a six-membered ring and 
a free hydroxyl group, plays an important role in determining the antiproliferative 
activity of (15) against melanoma cell lines. Therefore, on the basis of the reported 
pharmacological results, further investigations could be performed in order to 
achieve additional information on the structure-activity relationship of these class of 
sesquiterpenoids; given the selectivity of the eudesmane, for example, some 
analogues can be designed and tested, to obtain derivatives with higher potency and 
selectivity, for the development of new antiproliferative lead compounds. 
 
4.9 Experimental section 
 
4.9.1 Plant material, extraction and isolation 
 
The aerial parts of six Daucus virgatus (Poir.) Maire species (weight approx. 2.0 
Kg) were collected during the flowering stage in the Northwest of Tunisia (Biserta, 
GPS coordinates 37°18’19’’N, 9°51’15’’E) on May 2013 and identified by one of 
the authors (R. E. M.). Voucher specimens [AP; 00117/2013] were deposited in local 
Herbaria of both the Faculty of Pharmacy of Monastir and the Faculty of Sciences of 
Biserta. 
2.0 Kg of aerial parts were dried in the shade for 4-5 days at room temperature in a 
well-ventilated area (dry weight 0.95 g), then comminuted to powder, and 
exhaustively extracted by maceration in methanol (3 x 6L) to afford 130 g of crude 
extract after removal of the solvent in vacuum. The whole methanol extract was 
dissolved in water (500 mL) and then successively partitioned against n-hexane (2 x 
400 mL) CH2Cl2 (3 x 500 mL), and n-butanol (3 x 500 mL) to yield 40 g, 14 g and 
45 g of organic phases, respectively. The CH2Cl2 extract (14 g) was subjected to 
MPLC over a silica gel column (230-400 mesh) and eluted with the following solvent 
gradient: n-hexane (0.8 L), n-hexane/EtOAc 8:2 (1.0 L), n-hexane/EtOAc 7:3 (1.0 
L), n-hexane/EtOAc 6:4 (1.0 L), n-hexane/EtOAc 4:6 (1.0 L), n-hexane/EtOAc 2:8 
(1.0 L), EtOAc (0.8 L), EtOAc/MeOH 9:1 (1.0 L), EtOAc/MeOH 7:3 (1.0 L, 
EtOAc/MeOH 1:1 (1.0 L), MeOH (2.0 L). Four subfractions were collected for each 
elution solvent/mixture and the 44 subfractions thus obtained were pooled together 
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on the basis of their TLC profile. Fifteen fractions (1-15) resulted from this procedure 
and they were further purified by normal- and reverse-phase HPLC.  
Fraction 5 (93 mg), eluted with n-hexane−EtOAc, 8:2, was separated first by normal-
phase HPLC (n-hexane−EtOAc, 85:15, flow rate 1.0 mL/min) and then by RP-HPLC 
(MeOH−H2O, 75:25, flow rate 1.0 mL/min), yielding Daucovirgolide G (7, 21.5 
mg). Fraction 7 (116 mg), eluted with n-hexane−EtOAc, 7:3, was separated by HPLC 
(n-hexane−EtOAc, 7:3, flow rate 1.0 mL/min) to afford pure daucovirgolide E (5, 
28.1 mg), daucovirgolide F (6, 21.2 mg), and daucovirgolide H (8, 1.1 mg). Fraction 
8 (161 mg), eluted with n-hexane−EtOAc, 7:3, was separated by HPLC (n-hexane−
EtOAc, 6:4, flow rate 1.0 mL/min) to afford daucovirgolide C (3, 4.3 mg). Fraction 
9 (906 mg), eluted with n-hexane−EtOAc, 6:4, was subjected to chromatography over 
a silica gel column (70−230 mesh) eluting with a solvent gradient of increasing 
polarity from n-hexane−EtOAc 7:3 to EtOAc 100%, and finally EtOAc−MeOH, 1:1. 
Fraction 5 (132 mg) of the latter column, eluted with n-hexane−EtOAc, 6:4, was 
further fractionated by HPLC (n-hexane−EtOAc, 7:3, flow 3.0 mL/min) to obtain 
daucovirgolide B (2, 30.0 mg) and daucovirgolide A (1, 22.2 mg) in the pure state. 
Fraction 10 (1.08 g), eluted with n-hexane−EtOAc, 5:5, was subjected to 
chromatography over a silica gel column (70−230 mesh) eluting with a solvent 
gradient of increasing polarity from n-hexane−EtOAc, 7:3, to EtOAc, and finally 
EtOAc−MeOH (1:1). Fraction 4 (84.5 mg), eluted with n-hexane EtOAc, 7:3, was 
further purified by HPLC (n-hexane−EtOAc, 65:35, flow 1.0 mL/min) to obtain 
daucovirgolide D (4, 3.5 mg). 
Fraction 5 (93 mg), eluted with n-hexane/ EtOAc 8:2, was separated by HPLC (n-
hexane/EtOAc 85:15, flow rate 1.0 mL/min) to afford vaginatin (13, 7.2 mg, rt 4.2 
min) and 6-methoxymellein (9, 2.6 mg, rt 6.1 min) in the pure state and a subfraction 
(subfraction 10) whose further purification by RP-HPLC (MeOH/H2O 7:3, flow rate 
0.5 mL/min) yielded laserine oxide (11, 1.6 mg, rt 8.3 min), elemavirgolide (16, 4.4 
mg, rt 9.5 min) and vaginatin B (14, 0.8 mg, rt 9.9 min). Fraction 6 (193 mg), eluted 
with n-hexane/EtOAc 6:4, was separated by HPLC (n-hexane/EtOAc 65:35, flow 
rate 1.0 mL/min) to afford pure matairesinol (10, 3.0 mg, rt 5.1 min) and a fraction 
that was further purified by RP-HPLC (MeOH/H2O 6:4, flow rate 1.0 mL/min) to 
obtain eudesmane (15) (1.3 mg, rt 6.2 min). Fraction 7 (116 mg), eluted with n-
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hexane/EtOAc 7:3, was separated by HPLC (n-hexane/EtOAc 7:3, flow rate 1.0 
mL/min) and a subfraction (subfraction 14) was further purified by RP-HPLC 
(MeOH/H2O 7:3, flow rate 1.0 mL/min) to obtain pure 6-hydroxycamphor (12, 2.2 
mg, rt 4.4 min). 
 
4.9.2 Spectroscopic data for the isolated compounds 
 
Daucovirgolide A (1): colorless oil, [α]D +42.6 (c 0.09, CHCl3); ECD (MeOH) λmax 
(Δε) 208 (−6.8), 229 (+5.2) nm; 1H NMR (CDCl3, 500 MHz), see Table 1; 13C NMR 
(CDCl3, 125 MHz), see Table 2; ESIMS m/z 387 [M + Na] 
+; HRESIMS m/z found 
387.1773 (C20H28O6Na requires 387.1784). 
Daucovirgolide B (2): colorless oil; [α]D +59.0 (c 0.01, CHCl3); ECD (MeOH) λmax 
(Δε) 211 (−6.5), 232 (+5.8) nm; 1H NMR (CDCl3, 500 MHz) δH 6.08 (1H, qq, J = 
7.3, 1.1 Hz, H-3′), 5.35 (1H, m, H-1), 5.12 (1H, dd, J = 7.6, 1.3 Hz, H-6), 4.79 (1H, 
dd, J = 10.3, 1.1 Hz, H-8), 2.80 (1H, bs, OH-11), 2.60 (1H, bs, H-5), 2.33 (1H, dd, J 
= 1.3, 1.1 Hz, H-7), 2.32 (2H, overlapped, H-2), 2.13 (1H, m, H-3b), 2.06 (1H, m, H-
9b), 2.01 (1H, m, H-9a), 1.98 (3H, d, J = 7.3 Hz, H- 4′), 1.82 (3H, s, H-5′), 1.78 
(3H, s, H-14), 1.56 (3H, s, H-13), 1.30 (3H, s, H-15), 1.22 (1H, m, H-3a); 13C NMR 
(CDCl3, 125 MHz) δC 179.2 (C-12), 166.2 (C-1′), 140.5 (C-3′), 130.8 (C-10), 
128.6 (C-1), 127.3 (C-2′), 77.3 (C-8), 71.6 (C-11), 70.7 (C-6), 65.7 (C-5), 59.5 (C-
4), 49.2 (C-7), 40.7 (C-9), 37.3 (C-3), 30.0 (C-13), 25.2 (C-14), 23.6 (C-2), 20.3 (C-
5′), 16.7 (C-15), 16.1 (C-4′); ESIMS m/z 387 [M + Na]+; HRESIMS m/z found 
387.1795 (C20H28O6Na requires 387.1784). 
Daucovirgolide C (3): colorless oil, [α]D +68.8 (c 0.03, CHCl3); ECD (MeOH) λmax 
(Δε) 210 (−6.2), 227 (+5.4) nm; 1H NMR (CDCl3, 500 MHz), see Table 1; 13C NMR 
(CDCl3, 125 MHz), see Table 2; ESIMS m/z 419 [M + Na] 
+; HRESIMS m/z found 
419.1681 (C20H28O8Na requires 419.1682). 
Daucovirgolide D (4): colorless oil, [α]D + 4.9 (c 0.01, CHCl3); 1H NMR (CDCl3, 
500 MHz), see Table 1; 13C NMR (CDCl3, 125 MHz), see Table 2; ESIMS m/z 387 
[M + Na] +; HRESIMS m/z found 387.1774 (C20H28O6Na requires 387.1784). 
Mosher Ester Derivatization of Daucovirgolide D. Two aliquots of daucovirgolide 
D (4) (1.0 mg, 2.6 μmol) were treated with R-MTPA and S-MTPA chloride (30 μL) 
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in 400 μL of dry pyridine with a catalytic amount of DMAP overnight at rt. Then, 
the solvent was removed and the products were purified by HPLC (n-hexane−EtOAc, 
97:3) to obtain, respectively, the S-MTPA ester 4a (0.9 mg) and the R-MTPA ester 
4b (1.1 mg). 
S-MTPA ester 4a: colorless, amorphous solid; 1H NMR (CDCl3, 500 MHz) δH 6.10 
(1H, qq, J = 6.8, 1.1 Hz, H-3′), 5.55 (1H, d, J = 10.8 Hz, H-9), 5.48 (1H, overlapped, 
H-3), 5.48 (1H, overlapped, H- 6), 5.30 (1H, t, J = 10.8 Hz, H-8), 5.14 (1H, bs, H-
15a), 5.01 (1H, bs, H-15b), 3.29 (1H, t, J = 10.8 Hz, H-7), 2.60 (1H, m, H-1a), 2.41 
(1H, overlapped, H-5a), 2.39 (1H, overlapped, H-5b), 2.31 (1H, m, H-1b), 1.98 (3H, 
d, J = 6.8 Hz, H3-4′), 1.95 (3H, bs, H3-5′), 1.95 (1H, overlapped, H-2a), 1.88 
(1H, m, H-2b), 1.76 (3H, s, H3-14), 1.51 (3H, s, H3-13); (+)-ESIMS m/z 581 [M + 
H]+, 603 [M + Na]+. 
R-MTPA ester 4b: colorless, amorphous solid; 1H NMR (CDCl3, 500 MHz) δH 6.10 
(1H, qq, J = 6.8, 1.1 Hz, H-3′), 5.48 (1H, d, J = 10.8 Hz, H-9), 5.46 (1H, overlapped, 
H-3), 5.46 (1H, overlapped, H- 6), 5.14 (1H, t, J = 10.8 Hz, H-8), 5.07 (1H, bs, H-
15a), 4.99 (1H, bs, H-15b), 3.11 (1H, t, J = 10.8 Hz, H-7), 2.47 (1H, m, H-1a), 2.36 
(1H, overlapped, H-5a), 2.30 (1H, overlapped, H-5b), 2.21 (1H, m, H-1b), 2.07 (1H, 
overlapped, H-2a), 2.05 (1H, m, H-2b), 1.95 (3H, d, J = 6.8 Hz, H3-4′), 1.89 (3H, 
bs, H3-5′), 1.68 (3H, s, H3-14), 1.46 (3H, s, H3- 13); (+)-ESIMS m/z 581 [M + 
H]+, 603 [M + Na]+. 
Daucovirgolide E (5): colorless oil; [α]D +59.7 (c 0.01, CHCl3); 1H NMR (CDCl3, 
500 MHz) δH 6.22 (1H, qq, J = 7.3, 1.3 Hz, H-3′), 5.71 (1H, dd, J = 6.0, 1.3 Hz, H-
6), 5.12 (1H, d, J = 6.0 Hz, H-5), 4.83 (1H, ddd, J = 11.9, 6.2, 1.9 Hz, H-8), 3.01 (1H, 
overlapped, H-3″), 3.01 (1H, overlapped, H-7), 2.81 (1H, dd, J = 11.0, 1.3 Hz, H-
1), 2.26 (1H, m, H-3b), 2.25 (1H, m, H-3a), 2.18 (2H, m, H-9), 2.07 (1H, overlapped, 
H-2b), 2.06 (3H, d, J = 7.3 Hz, H-4′), 1.91 (3H, s, H-5′), 1.86 (3H, s, H-13), 1.75 
(3H, s, H-15), 1.50 (1H, m, H-2a), 1.47 (3H, s, H-5″), 1.41 (3H, s, H-14), 1.26 (3H, 
d, J = 5.4 Hz, H-4″); 13C NMR (CDCl3, 125 MHz) δC 173.7 (C-12), 168.6 (C-1″), 
167.6 (C-1′), 141.7 (C-3′), 138.6 (C-4), 127.1 (C-2′), 125.1 (C-5), 77.7 (C-11), 
76.0 (C-8), 70.9 (C-6), 62.2 (C-1), 60.2 (C-3″), 59.7 (C-2″), 57.1 (C- 10), 50.7 (C-
7), 42.5 (C-9), 36.6 (C-3), 25.0 (C-13), 24.1 (C-2), 22.1 (C-14), 20.8 (C-5′), 19.0 
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(C-5″), 17.5 (C-15), 16.4 (C-4′), 13.6 (C- 4″); ESIMS m/z 485 [M + Na]+; 
HRESIMS m/z found 485.2158 (C25H34O8Na requires 485.2151). 
Daucovirgolide F (6): colorless oil; [α]D +91.7 (c 0.01, CHCl3); 1H NMR (CDCl3, 
500 MHz) δH 6.21 (1H, qq, J = 7.3, 1.1 Hz, H-3′), 5.34 (1H, m, H-1), 5.00 (1H, dd, 
J = 6.6, 1.3 Hz, H-6), 4.82 (1H, m, H-8), 3.01 (1H, q, J = 5.4 Hz, H-3″), 2.89 (1H, 
t, J = 1.3 Hz, H-7), 2.58 (1H, d, J = 6.6 Hz, H-5), 2.35 (2H, m, H2-2), 2.13 (1H, dt, J 
= 13.3, 3.4 Hz, H-3b), 2.09 (1H, overlapped, H-9b), 2.04 (1H, overlapped, H-9a), 
2.03 (3H, d, J = 7.5 Hz, H-4′), 1.88 (3H, s, H-5′), 1.87 (3H, s, H-13), 1.83 (3H, s, 
H-14), 1.49 (3H, s, H-5″), 1.33 (3H, s, H-15), 1.28 (3H, d, J = 5.4 Hz, H-4″), 1.18 
(1H, q, J = 11.4 Hz, H-3a); 13C NMR (CDCl3, 125 MHz) δC 174.1 (C-12), 168.1 (C-
1″), 167.3 (C-1′), 141.9 (C-3′), 130.2 (C-10), 128.9 (C-1), 126.9 (C-2′), 77.6 
(C-11), 77.3 (C-8), 72.8 (C-6), 65.2 (C-5), 60.0 (C-3″), 59.8 (C-2″), 59.6 (C- 4), 
48.0 (C-7), 40.7 (C-9), 37.5 (C-3), 25.5 (C-13), 25.2 (C-14), 24.0 (C-2), 20.6 (C-5′
), 18.6 (C-5″), 16.4 (C-15), 16.2 (C-4′), 13.5 (C- 4″); ESIMS m/z 485 [M + Na]+; 
HRESIMS m/z found 485.2160 (C25H34O8Na requires 485.2151). 
Daucovirgolide G (7): colorless oil, [α]D +49.1 (c 0.03, CHCl3); 1H NMR (CDCl3, 
500 MHz), see Table 1; 13C NMR (CDCl3, 125 MHz), see Table 2; ESIMS m/z 469 
[M + Na] +; HRESIMS m/z found 469.2195 (C25H34O7Na requires 469.2202). 
Daucovirgolide H (8): colorless oil; [α]D +49.1 (c 0.03, CHCl3); 1H NMR (CDCl3, 
500 MHz) δH 6.19 (1H, qq, J = 7.3, 1.1 Hz, H-3′), 6.06 (1H, s, H-14a), 5.88 (1H, s, 
H-14b), 5.57 (1H, dd, J = 5.6, 1.1 Hz, H- 6), 4.94 (1H, dd, J = 12.2, 4.6 Hz, H-8), 
4.87 (1H, d, J = 5.6 Hz, H-5), 3.54 (1H, m, H-9a), 3.36 (1H, m, H-2a), 3.01 (1H, q, J 
= 10.8 Hz, H- 3″), 2.69 (1H, m, H-7), 2.48 (1H, m, H-3a), 2.28 (1H, overlapped, H- 
2b), 2.28 (1H, overlapped, H-3b), 2.15 (1H, m, H-9b), 2.05 (3H, d, J = 7.3 Hz, H-4
′), 1.89 (3H, s, H-5′), 1.83 (3H, s, H-13), 1.74 (3H, s, H- 15), 1.46 (3H, s, H-5″
), 1.24 (3H, d, J = 5.4 Hz, H-4″); 13C NMR (CDCl3, 125 MHz) δC 204.1 (C-1), 174.0 
(C-12), 168.5 (C-1″), 167.4 (C-1′), 141.2 (C-3′), 136.4 (C-4), 127.5 (C-5), 127.0 
(C-2′), 77.6 (C- 11), 70.7 (C-6), 59.9 (C-3″), 59.7 (C 2″), 49.6 (C-7), 38.2 (C-
3), 38.1 (C-9), 26.1 (C-2), 25.4 (C-13), 20.4 (C-5′), 18.5 (C-5″), 17.1 (C-15), 16.2 
(C-4′), 13.5 (C-4″); ESIMS m/z 483 [M + Na]+; HRESIMS m/z found 483.1987 
(C25H32O8Na requires 483.1995). 
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Vaginatin B (14): colorless oil, [α]D -31 (c 0.04, CHCl3); 1H NMR (CDCl3, 500 
MHz): δH 6.09 (1H, qq, J = 7.2, 1.3 Hz, H-3’), 6.04 (1H, qq, J = 7.5, 1.6 Hz, H-3’’), 
5.99 (1H, d, J = 7.8 Hz, H-9), 5.34 (1H, d, J = 7.8 Hz, H-10), 4.57 (1H, d, J = 13.2 
Hz, H-14a), 4.51 (1H, d, J = 13.2 Hz, H-14b), 2.43 (1H, overlapped, H-6a), 2.42 (1H, 
overlapped, H-3a), 2.26 (1H, m, H-4), 2.24 (1H, m, H-7a), 2.21 (1H, m, H-3b), 2.10 
(1H, overlapped, H-6b), 2.10 (1H, overlapped, H-7b), 2.05 (1H, m, H-11), 1.98 (3H, 
dd, J = 7.2, 1.5 Hz, H-40), 1.96 (3H, dd, J = 7.5, 1.4 Hz, H-4’’), 1.90 (3H, s, H3-5’), 
1.84 (3H, s, H3-5’’), 1.07 (3H, s, H3-15), 1.06 (3H, d, J = 6.8 Hz, H3-12), 0.99 (3H, 
d, J = 6.8 Hz, H3-13); 
13C NMR (CDCl3, 125 MHz) δC 219.7 (C-2), 167.9 (C-1’), 
166.1 (C-1’’), 146.5 (C-8), 140.3 (C-3’’), 138.8 (C-3’), 127.9 (C-2’), 126.9 (C-2’’), 
119.9 (C-9), 82.6 (C-5), 75.1 (C-10), 69.1 (C-14), 60.2 (C-1), 51.0 (C-4), 38.5 (C-3), 
37.3 (C-6), 29.3 (C-7), 26.7 (C-11), 25.0 (C-12), 21.2 (C-13), 20.7 (C-4’), 20.5 (C-
4’’), 18.2 (C-15), 15.7 (C-5’’), 15.5 (C-5’). ESIMS (positive ions) m/z 455 [M + Na] 
+; HR-ESIMS m/z 455.2412; calcd. for C25H36NaO m/z 455.2410. 
Compound (15): brown gum, [α]D +28.0 (c 0.01, CHCl3); 1H and 13C NMR: see 
Appendino et al., 1993 (Please notice that the resonances reported for C-1 and C-8 
must be inverted). ESIMS (positive ions) m/z 387 [M + Na] +; HR-ESIMS m/z 
387.1779; calcd. for C20H28NaO6 m/z 387.1784. 
Elemavirgolide (16): colorless oil; [α]D - 2 (c 0.5, CHCl3); 1H NMR and 13C NMR 
(CDCl3): see Table 3.1. ESI-MS (positive ions) m/z 371 [M + Na] 
+; HRESIMS m/z 
371.1830; calcd. for C20H28NaO5 m/z 371.1834. 
 
4.9.3 Evaluation of Transmission Blocking Activity 
 
Assessment of in Vitro Transmission-Blocking Activity. The effects of 
daucovirgolides 1−3 and 5−7 on the development in vitro of P. berghei early 
sporogonic stages, i.e., on gametes, zygotes, and ookinetes developing within 24 h in 
the mosquito midgut after ingestion of gametocytemic blood, were evaluated by 
employing the rodent malaria strain P. berghei CTRPp.GFP and the ookinete 
development assay, according to Delves et al., with slight modifications. 
To obtain mouse blood with high numbers of mature gametocytes, mice were 
pretreated with phenylhydrazine (120 mg/kg ip) 4 days prior to infection with P. 
berghei CTRPp.GFP through ip injection of 107 infected red blood cells (RBCs). 
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Gametocytemia was then checked 4 days postinfection by microscopic examination 
of thin blood films, and the maturity of microgametocytes verified by testing their 
capacity to generate flagellate microgametes in the exflagellation assay. Mice with 
mature female and male gametocytes according to thin Giemsastained films and 
showing more than three exflagellation centers per 1000 RBCs were used as blood 
donors for the subsequent ookinete development assay. 
Permission to perform animal experiments was obtained by University Research 
Ethics Committee (protection of animals used for experimental and other scientific 
purposes) of the University of Camerino, protocol number UREC_CAM_2015/18. 
Ookinete Development Assay. The culture medium was composed of RPMI 1640 
containing 25 mM HEPES, 25 mM sodium bicarbonate, 50 mg/L hypoxanthine, 100 
μM xanthurenic acid, and 20% heat-inactivated fetal bovine serum, supplemented 
with 100 units/mL penicillin and 100 μg/mL streptomycin and set at pH 7.4. For the 
ookinete cultures, 96-well microplates (Nunc, Roskilde, Denmark) were employed; 
dimethyl sulfoxide (DMSO) was used as negative control and vernodalol as positive 
reference. In brief, 10 μL of each dilution was added to the microplate wells 
containing 80 μL of ookinete culture medium to obtain the desired test 
concentrations. Then, 10 μL aliquots of blood obtained by cardiac puncture from 
gametocytemic mice were transferred to the microplate wells containing test 
compounds or solvent controls and mixed rapidly. 
Plates were then incubated at 19 °C for 24 h. At the end of incubation, well contents 
were mixed and 3.5 μL of cell suspension from each well was withdrawn and diluted 
with serum-free medium at a ratio of 1:25 in a separate 96-well microplate. This 
dilution step permitted, after cell settlement, obtaining a monolayer of blood cells 
and parasites, a condition that was required for an accurate microscopic examination. 
Green fluorescent protein-expressing zygotes and ookinetes were visualized and 
counted using a Zeiss fluorescence microscope (400× magnification). Each test 
substance was examined in three replicate wells, and experiments were repeated at 
least twice. The percent inhibition of ESS development induced by the 
extracts/molecules was calculated as follows: 
 
(1 - mean ESS count test wells/mean ESS count solvent control 
wells) x 100 
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Distinct counts of zygotes and ookinetes were effected based on the shape of the ESS: 
round-shaped forms were counted as zygotes, while roundish forms with nose-like 
protrusions and banana-like elongated forms were considered as maturing and mature 
ookinetes. 
 
4.9.4 Antiproliferative activity 
 
Human immortalized keratinocytes (Hacat) were purchased from Lonza 
(Walkersville, MD, USA). The melanoma cell line A375 and the human breast 
adenocarcinoma cell line MCF-7 were purchased from Sigma-Aldrich (Milan, Italy). 
All cell lines were cultured in Dulbecco's modified Eagle's medium (DMEM) 
containing 10% fetal bovine serum, 2 mmol/L L-glutamine, 100 μmol/L non-
essential amino acids, penicillin (100 U/mL), streptomycin (100 μg/mL) and 1 
mmol/L sodium pyruvate (all from Sigma-Aldrich, Milan, Italy). Compounds 1-5, 7 
and 8 were diluted in DMSO to prepare a stock solution of 100 μM. All cell lines 
used in this study were characterized by the cell bank where they were purchased. 
Cell proliferation was measured by the 3-[4,5-dimethyltiazol-2yl]-2,5 diphenyl 
tetrazolium bromide (MTT) assay as previously described (De Cicco et al., 2017). 
The cells were seeded on 96 well plates (1 104 cells/well) and treated with the 
compounds (1-3-10-30-100 μM) for 24-48-72 h before adding 25 μL of MTT (Sigma, 
Milan, Italy) (5 mg/mL in saline). Cells were incubated for additional 3 h at 37° C. 
Thereafter, cells were lysed and dark blue crystals were dissolved in a solution 
containing 50% (vol/vol) N, N-dimethylformamide, 20% (w/vol) sodium 
dodecylsulfate with an adjusted pH of 4.5. The OD of each well was measured with 
a microplate spectrophotometer (TitertekMultiskan MCC/340) equipped with a 620-
nm filter. Results were expressed as IC50 (μM). ADA (De Cicco et al., 2017) was 
used as a positive control (IC50 on A375 = 51.4 μM). 
 
4.9.5 Computational Calculations 
 
A preliminary conformational search on each pair of enantiomers of 
daucovirgolide A (1) was performed by Simulated Annealing in the INSIGHT II 
  
 
87 
 
  
    Plasmodium transmission blocking and antiproliferative metabolites from D. virgatus  Chapter 4 
package. Using the steepest descent followed by the quasi-Newton−Raphson method 
(VA09A), the conformational energy was minimized. Restrained simulations were 
carried out for 500 ps using the CVFF force field as implemented in Discover 
software (Accelrys, San Diego, CA, USA). 
The simulation started at 1000 K, and then the temperature was decreased stepwise 
to 300 K. The final step was again the energy minimization, performed in order to 
refine the structures obtained, using the steepest descent and the quasi-Newton−
Raphson (VA09A) algorithms successively. Both dynamic and mechanic 
calculations were carried out using 1 (kcal/mol)/Å 2 flat well distance restraints. One 
hundred structures were thus generated. To simulate the solvent chosen for ECD 
analysis, a distance-dependent dielectric constant set to the value of MeOH at 298 K 
(ε 33.10) was used during the calculations. All optimizations were performed with 
the software package Gaussian 03, using the DFT functional mpw1pw91 and the 
basis set 6-31G(d). TDDFT calculations were run using the functional CAM-B3LYP 
and the basis sets 6-31G(d,p) including at least 30 excited states in all cases and using 
IEF-PCM for MeOH with Gaussian 03. The rotatory strength values were summed 
after a Boltzmann statistical weighting, and Δε values were calculated by forming 
sums of Gaussian functions centered at the wavelengths of the respective electronic 
transitions and multiplied by the corresponding rotatory strengths. The obtained ECD 
spectra were UV-corrected and compared to the experimental ones.
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CHAPTER 5: 
 
STUDIES TOWARDS THE TOTAL SYNTHESIS OF 
DAUCOVIRGOLIDE G 
 
5.1 Total synthesis of germacrane sesquiterpenes 
 
Total synthesis of germacranes and germacranolides has attracted the attention 
of synthetic chemists for many years, given their promising pharmacological 
activities and the possibility to employ the germacrane skeleton as intermediate to 
obtain sesquiterpene subclasses, such as elemanes, guaianes and eudesmanes.1 
Despite all the positive aspects, a drawback is represented by the instability of 
germacrane core to acidic, basic and thermal conditions, resulting in the formation of 
undesirable rearranged compounds.2 To date, there are several publications about the 
total synthesis of these molecules, but in many cases, the adopted approach is not 
readily reproducible or it does not result in a reasonable yield of the synthesized 
products; hence the challenge to perform an efficient synthetic route leading to target 
sesquiterpenes in bulk quantities. 
In the first part of this chapter, some relevant procedures for the total synthesis of 
germacrane derivatives will be reported, with particular attention to the formation of 
(E, E)-compounds. Then, the retrosynthetic and synthetic studies towards the total 
synthesis of daucovirgolide G, the most promising metabolite isolated from D. 
virgatus, will be described. 
 
5.1.1 The first total synthesis of a germacranolide: (+)-dihydrocostunolide  
 
The first germacrane sesquiterpene was synthesized by Corey and Hortmann in 
1963, employing a photolytic cleavage as strategy to forge the ten-membered 
carbocycle of (+)-dihydrocostunolide (4) (Scheme 5.1).3 Santonin (1), a natural 
product isolated from flowers of Artemisia cina possessing anthelmintic activity, was 
utilized as starting material to obtain a bicyclic conjugated diene (2); the latter was 
irradiated to give a mixture of starting bicyclic compound and cyclodecatriene (3), 
which was hydrogenated over Raney nickel to afford (+)-dihydrocostunolide in a 
very low yield (10%). 
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Scheme 5.1. The first total synthesis of (+)-dihydrocostunolide (4) 
 
 
In 1986, J. E. Burks, Jr. et al. reported the total synthesis of (+)-dihydrocostunolide 
(4) via tandem Cope-Claisen rearrangement (Scheme 5.2).4 The starting material of 
reaction, in this case, is represented by the triisopropylsilyl ketene acetal (5), which 
was obtained by treatment of the corresponding propionate ester with LDA and then 
with (i-Pr)3SiCl. Thermolysis of (5) at 200°C provided compound (7), after a tandem 
Cope-Claisen rearrangement; the latter, after hydrolysis with KF·2H2O and 
esterification with CH2N2 afforded (8) in 30% yield. The trisubstituted double bond 
of (8) was subjected to an epoxidation to give (9), which was in turn treated with 
OsO4 to obtain the hydroxyl lactone (10). After oxidation of (10) with pyridinium 
dichromate (PDC), followed by a diasteroselective reduction with NaBH4, mesylate 
(13) was prepared by treatment with MsCl. Compound (13) was deoxygenated with 
dimethyl diazomalonate and [(n-C7H15C02)2Rh]2 to give (14) in 66% yield. The anti-
elimination of (14) utilizing tetra-n-butylammonium oxalate led to the desired final 
product (4) in 48% yield.   
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Scheme 5.2. Synthesis of (+)-dihydrocostunolide (4) via tandem Cope-Claisen 
rearrangement. 
 
 
5.1.2 The total synthesis of (+)-costunolide  
 
In 1977, Grieco and Nishizawa reported the first total synthesis of (+)-
costunolide (24) (Scheme 5.3), a germacranolide isolated from the roots of 
Saussurea costus.5 Santonin (1) was utilized as starting material to obtain keto 
lactone (15), after the hydrogenation of two double bonds and epimerization at C-4. 
The keto lactone (15) was treated with tosylhydrazine to give the corresponding 
hydrazone, which was in turn treated with an excess of lithium diisopropylamide in 
dry tetrahydrofuran at 0 °C to afford the crystalline olefin (16). Ozonolysis of olefin 
(16) and subsequent use of sodium borohydride led to the diol (17), which was 
subjected to treatment with o-nitrophenyl selenocyanate in pyridine-tetrahydrofuran 
(1:1), containing tributylphosphine, to give monoselenide (18). Oxidation of 
monoselenide (18) into olefinic alcohol (19) and conversion of the latter into selenide 
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(20), led to saussurea lactone (21) upon elimination of the 0-nitrophenylselenoxide. 
Subsequently, selenenylation of (21) afforded selenide (22); compound (22) was 
treated with hydrogen peroxide in tetrahydrofuran to obtain dehydrosaussurea 
lactone (23), which was subjected to thermolysis to give a 20% yield of crystalline 
(+)-costunolide (24). 
This synthetic approach is based on the naturally occurring equilibrium between 
germacrane and elemane sesquiterpenes; thus, drawing on thermal conversion from 
1,2-divinylcyclohexanes to cyclodecadienes, it was used a Cope rearrangement to 
obtain a germacrane derivative.  
 
 
 
Scheme 5.3. Total synthesis of (+)-costunolide (24). 
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In 1986, Kitagawa et al. described an alternative route to synthesize (+)-costunolide;6 
as outlined in Scheme 5.4, it was employed a low-valent chromium reagent to 
synthesize the ten-membered carbocycle, starting from E,E-farnesyl acetate (25), 
which was treated with selenium dioxide to obtain ω-hydroxy-farnesyl acetate (26) 
in 53% yield. The latter was subjected to a bromination utilizing carbon tetrabromide 
and trioctyl phosphine in ether to afford ω-bromo-farnesyl acetate (27) in 72% yield. 
Upon alkaline hydrolysis and oxidation with PCC-AcONa in CH2Cl2, ω-bromo-
farnesal (28) was obtained in 88% yield. As mentioned, the cyclization of the 
carbocyclic ring (29) was obtained with CrCl3-LiAlH4 (2:1) in N,N-
dimethylformamide at room temperature in 42% yield, as racemic mixture. Thus, the 
treatment of (29) with t-butyldimethylsilyl chloride (TBDMSCI), hydroboration-
oxidation with 9- borabicyclo [3.3.1] nonane (9-BBN), and alkaline hydrogen 
peroxide oxidation, afforded the diol-monosilyl ether (30). Subsequent oxidation 
with pyridinium dichromate (PDC) and desilylation using tetrabutylammonium 
fluoride followed by lactonization in acidic conditions, led to (+)- dihydrocostunolide 
(4) in 68% yield. The last step involved the use of lithium diisopropylamide (LDA) 
and diphenyl diselenide, followed by the treatment with hydrogen peroxide to give 
(+)-costunolide (24) in 49% yield. 
 
Scheme 5.4. Alternative route for the synthesis of (+)-costunolide  
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5.1.3 Total synthesis of (±)-acoragermacrone  
 
In 1983, Takahashi et al. reported a new method for the synthesis of (±)-
acoragermacrone (39) (Scheme 5.5),7 founded on an intramolecular alkylation of 
cyanohydrins protected as 1-ethoxyethyl ether (EEO). Aldehyde (32), prepared 
starting from geranyl acetate (31), was subjected to the addition of 
isopropylmagnesium bromide and tosylation of the resulting alcohol gave (33); the 
1-ethoxyethyl group of (33) was removed and allylic oxidation utilizing MnO2 gave 
aldehyde (34) in 85% yield. The cyanohydrin trimethylsilyl ether (35) was obtained 
after treatment of (34) with trimethylsilyl cyanide, KCN/dicyclohexyl-18-crown-6-
complex at 0°. Subsequently, after deprotection of compound (35) and treatment of 
the cyanohydrins (36) with ethyl vinyl ether, the resulting protected cyanohydrins 
(37) was treated with lithium bis(trimethylsilyl)amide in refluxing benzene to obtain 
the cyclization product (38) in 57% yield. Acid and basic treatments (PPTS/MeOH, 
40°C, 1 h and 1% aq. NaOH, O°C, 1 min), led to (±)-acoragermacrone (39).  
 
 
 
Scheme 5.5. Synthesis of (±)-acoragermacrone. 
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5.1.4 Baran’s approach to the formation of the germacranolides’ ten-
membered carbocycle 
 
An elegant and efficient procedure for the preparation of the germacrane core, 
starting from farnesol (40), was reported by Baran et al. in 2012.1 The key-step 
reaction of the synthesis was a diastereoselective Pd-catalyzed intramolecular 
coupling reaction between the aldehyde and allylchloride functional groups present 
in intermediate (43). Remarkably, the reaction proceeded through the formation of 
an allyl anion, generated by reaction of the allyl chloride with [PdCl2(PPh3)2] and 
diethyl zinc in N,N-dimethylacetamide (DMA), which is able to react with the 
aldehyde to provide the 10-membered ring. As outlined in Scheme 5.6, farnesol was 
initially converted to epoxy aldehyde (41) using Sharpless epoxidation and Parick-
Doering oxidation. Regioselective chlorination of (42), with concomitant 
transposition of the 10,11- double bond to the terminal position, provided chlorinated 
epoxy aldehyde (43) in 63% yield. Cyclisation of the latter intermediate, using the 
method described before, led to the germacrane ring system (44). 
 
 
 
 
 
Scheme 5.6. Preparation of the ten-membered carbocycle using Baran’s approach 
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5.2 Retrosynthetic analysis of daucovirgolide G 
 
The retrosynthetic pathway designed for the preparation of daucovirgolide G 
(45) is outlined in Scheme 5.7. It was initially envisioned that the fused-bicyclic 
system of the final target (45) could be readily obtained from compound (46) via an 
initial stereocontrolled dihydroxylation (Sharpless dihydroxylation) and subsequent 
oxidation, followed by lactonization of the resulting α-hydroxy acid. An 
intramolecular Corey-Seebach reaction could be employed to prepare the ten-
membered ring. Successive deprotection of the dithiane, stereocontrolled reduction 
with DIBAL-H and SN2 reaction under Mitsunobu conditions would provide the 
acetate group with the correct configuration at C-8 (conversion of compound 47 to 
46). The preparation of substrate 47 for the intramolecular Corey-Seebach reaction, 
requires the installation of two functionalities: a dithiane and a tosylate group. The 
dithiane functionality, used as an acyl anion equivalent, could be introduced on 47 
via sequential reduction and thioacetalization of 48. The tosylate leaving group, on 
the other hand, could be readily installed via tosylation of allylic alcohol 48. In turn, 
key intermediate 48 could be obtained via a diastero- and regio- selective addition of 
dienolate 49 to aldehyde 50. Finally, aldehyde 50 could be synthesized from geranyl 
acetate, a commercially available monoterpene, via a high regioselective allylic 
hydroxylation, followed by protection of resulting allylic alcohol as TBS ether, 
hydrolysis of the acetyl group and oxidation to aldehyde 50. Although this route is 
suitable for asymmetric synthesis, it was initially explored the preparation of racemic 
compound 45. 
 
Daucovirgolide G 
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Scheme 5.7. Retrosynthetic scheme for the preparation of daucovirgolide G. 
 
 
5.3 Synthesis of daucovirgolide G 
 
5.3.1 Preparation of (2E,6E)-8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl 
acetate  
 
 
 
 
 
Scheme 5.8. Preparation of allylic alcohol 51 with SeO2. 
 
 
The first step of our synthetic route required the regioselective hydroxylation of 
geranyl acetate. This reaction was carried out following a procedure reported by 
Sharpless et. al.8 As outlined in Scheme 5.8, the process involved the treatment of 
geranyl acetate with catalytic amounts of selenium dioxide and salicylic acid, along 
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with stoichiometric amounts of tert-butyl hydroperoxide (TBHP) as terminal oxidant. 
The NMR of the crude material revealed that the reaction proceeded with high 
regioselectivity; thus, the product was mostly contaminated only by variable amounts 
of aldehyde (52) (20-30 %), which was readily removed from the mixture by column 
chromatography (DCM/Ethyl acetate 8:2). Pure allylic alcohol (51) was obtained in 
61% yield. 
 
5.3.2 Preparation of (2E,6E)-8-((tert-butyldimethylsilyl) oxy)-3,7-
dimethylocta-2,6-dien-1-ol (53) 
 
 
 
 
 
Scheme 5.9. Conversion of allylic alcohol 51 to intermediate 53 via sequential 
silylation and hydrolysis. 
 
 
Protection of the free hydroxyl group presents in allylic alcohol 51 was carried 
out using a standard protocol for the protection of primary alcohols as silyl ethers 
(Scheme 5.9). 9 The desired protected product 52 was obtained in quantitative yield. 
Successive treatment of intermediate 52 with a methanolic solution of K2CO3 
provided compound 53 in 87% yield. Remarkably, the conversion of compound 51 
to 53 didn’t require any purification by column chromatography. 
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5.3.3 Preparation of (2E,6E)-8-((tert-butyldimethylsilyl)oxy)-3,7-
dimethylocta-2,6-dienal (50) 
 
 
 
 
 
Scheme 5.10. Oxidation of protected allylic alcohol 53 to aldehyde 50. 
 
 
The oxidation of an allylic alcohol to aldehyde has been reported in the literature 
using MnO2.
10 Unfortunately, the reactivity of this oxidizing system is known to be 
variable and could lead to non-reproducible results. As a consequence, we attempted 
other procedures that required the use of activating reagents of DMSO (Swern or 
Parick-Doering oxidation). Our preliminary investigations revealed that the reaction 
could be carried out for our substrate efficiently using Swern oxidation.11 
Unfortunately, the reaction gave non-reproducible results. In fact, careful analysis of 
the crude NMR revealed the presence of a variable amount of bis-aldehyde 54. We 
supposed that the impurity arose from the deprotection of the acid-labile TBS group. 
Hence, traces of HCl would be formed by hydrolysis of oxalyl chloride, and then a 
sequential deprotection and oxidation would lead to by-product 54. The low 
temperatures and strictly anhydrous conditions were other drawbacks that must be 
considered when carrying through this protocol. Subsequently, we explored Parick-
Doering oxidation for the preparation of compound 50.12 This procedure employed 
SO3·pyr complex as a mild activator of DMSO to perform the oxidation. 
Furthermore, the reaction could be run at room temperature under very mild 
conditions. To our delight, target compound 50 was obtained in excellent yield 
(92%). The pure product was then easily isolated from the mixture through a simple 
filtration over a small pad of silica gel. 
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5.3.4 Preparation of ethyl (2S,3R,4E,8E)-3,10-dihydroxy-5,9-dimethyl-2-
(prop 1-en-2-yl)deca-4,8-dienoate (anti-55a) 
 
 
 
 
 
Scheme 5.11. Synthetic strategies for the preparation of β-hydroxy carbonyl 
compounds 55 a-b and 56 via aldol condensation. 
 
 
Preparation of compounds 55a and 55b required the introduction of a β-hydroxy 
carbonyl group and an exo-methylene in the geranyl scaffold. We envisioned that this 
transformation could be carried out in a single process through an aldol reaction using 
dienolate 49a and 49b. It was preferred to avoid the use of dienolate 49c, in order to 
prevent the formation of product (56) as a result of vinylogous addition, which is 
known to be favorite when using soft nucleophiles (for example enolate aldehyde). 
 
 
 
 
Scheme 5.12 Pilot reactions on aldehyde (57). 
 
 
Several potential issues could derive from the aldol reaction on substrate 50; for this 
reason, we initially decided to perform a series of pilot reactions on the cheap and 
commercially available congener aldehyde 57, in order to find the best reagent and 
reaction conditions.  
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In fact, a competition between α versus γ addition on substrate 50 could potentially 
lead to regioselective problems. Further, with regards to the diastereoselectivity, the 
reaction could provide both sin and anti-products of 55 a-b.13  
After several trials, we discovered that the reaction could be carried out efficiently at 
low temperatures (-78 ˚C) using both ester 49a and amide 49b, with the predominant 
formation of the anti- diastereoisomer. This procedure, however, as shown by the 
crude NMR, was extremely selective only in the amide (49 b) case (more than 99% 
in favor of the anti-product). Therefore, we initially decided to progress our synthetic 
route using amide dienolate. 
 
 
 
 
Scheme 5.13. Preparation of anti-β-Hydroxy-amide 55b from aldehyde 50 and 
dienolate 49b. 
 
 
Once applied the optimized procedure to aldehyde 50, however, we observed that 
selectivity dropped down to 3:1 in favor of the anti-product 55b. Hopefully, the 
required anti-diastereoisomer was easily isolated from the mixture by column 
chromatography with a yield of 55-60% (the sin-isomer was obtained in 20% isolated 
yield).  
Unfortunately, as discussed in the next section of this chapter, the reduction of 
compound 59 to alcohol 60 was unsuccessful and it was necessary to use ester 
dienolate 49a to progress in our synthesis. 
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Scheme 5.14. Preparation of anti-β-Hydroxy-ester 55a from aldehyde 50 and 
dienolate 49a. LiEt3BH promoted retroaldol reaction for the conversion of sin-55a 
to 53. 
 
 
The reaction of aldehyde 50 with ester dienolate 49a provided the anti-product 55a 
in a good yield (52% of anti-product and 26% of the sin-product) and moderate 
diastereoselectivity (2:1 in favour of the anti diastereoisomer). We also discovered 
that treatment of the sin isomer with LiEt3BH (10 eq.), induced a retroaldol reaction 
with subsequent reduction of the resulting aldehyde. Hence, by reacting the sin-
product with LiEt3BH, we were able to transform the undesired diastereoisomer in 
compound 53, and this was then reintroduced in our synthetic route to obtain the 
required anti-55a product. The yield for this process is 78%, based on recovered 
reagent 53. 
 
 
5.3.5 Attempted synthesis of (2R,3R,4E,8E)-3,10-bis((tert-
butyldimethylsilyl)oxy)-5,9-dimethyl-2-(prop-1-en-2-yl)deca-4,8-dien-1-
ol (60). 
 
 
 
 
Scheme 5.15. Attempted preparation of alcohol 60 from amide 55b 
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Protection of the free hydroxyl group in compound 55b was carried out using a 
standard protocol for the silylation of secondary alcohols (Scheme 5.15). 
Delightfully, we obtained the desired protected material 59 in quantitative yield. 
Successive treatment of intermediate 59 with LiEt3BH, following the procedure 
reported by Brown et. el.,14 didn’t provide the desired product 60; thus, the starting 
material 59 was always recovered quantitatively. It is possible to explain this result 
considering that the reactivity of LiEt3BH is affected from the proximity of the 
sterically demanding TBS group. In order to enhance the reactivity of the reducing 
agent, we carried out the reaction at a higher temperature (60 ˚ C). Unfortunately, also 
in this case, we didn’t observe any conversion to the desired product and, once again, 
the starting material was fully recovered.  
 
 
5.3.6 Preparation of (2R,3R,4E,8E)-3,10-bis((tert-
butyldimethylsilyl)oxy)-5,9-dimethyl-2-(prop-1-en-2-yl)deca-4,8-dien-1-
ol from anti-β-Hydroxy-ester and attempted oxidation to aldehyde. 
 
 
 
 
Scheme 5.16. Preparation of ester 61 and reduction to alcohol 60. 
 
 
 
Given the inability to achieve the reduction of amide 55b to alcohol 60 utilizing 
LiEt3BH, it was possible to reintroduce ester 55a in the synthetic route. The latter 
was then reduced efficiently to compound 60 using LiAlH4(3 eq.). 
 
 
 
Scheme 5.17. Preparation of aldehyde 62. 
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We next explored the oxidation of alcohol 60 to aldehyde 62. Unfortunately, as 
shown in Scheme 5.17, any attempt to oxidise compound 60, using the Parikh–
Doering oxidation and the Dess Martin Periodinane, provided a complex mixture, 
containing only traces of the desired product. We are currently changing several 
reaction parameters (temperature, solvent, time of reaction) and investigating other 
reagents to increase the conversion to compound 62. For example, we envisioned that 
others mild oxidising systems could be used to perform this reaction. Among these, 
we are considering the TEMPO BAIB system or Ley–Griffith oxidation. We are also 
considering the direct conversion of the ester to the aldehyde using DIBAL at low 
temperature (-78 ˚C). 
 
5.4 Experimental section 
 
(2E,6E) -8-Hydroxy-2,6-dimethyl-2,6-octadienyl acetate (51): to a suspension 
of selenium dioxide (239 mg, 2.15 mmol, 0.03 equiv) and salicylic acid (1g, 7.2 
mmol, 0.1 equiv) in CH2Cl2 (116 mL) was added tert-butyl hydroperoxide (5.5M in 
nonane, 50 mL, 3.87 equiv), and the mixture was stirred for 15 min at room 
temperature. Then, geranyl acetate (14 g, 71 mmol, 1 equiv) was added to the 
suspension. After being stirred for another 20 h, the mixture was quenched with 
MnO2 and a solution of NaOH 1M was added. Successively, it was extracted with 
DCM and washed with brine. The organic layer was dried over anhydrous Na2SO4 
and concentrated in vacuo. The residue was chromatographed on silica gel 
(cyclohexane/ethyl acetate = 7/3) to give (51) (9.2 g, 61%) as a colorless oil.  
1H-NMR (400 MHz, CDCl3) : δ 5.32–5.38 (m, 2H), 4.58 (d, J = 7.5 Hz, 2H), 3.99 (s, 
2H), 2.18 (dd, J = 7.0, 14.0 Hz, 2H), 2.08 (dd, J = 7.0, 14.0 Hz, 2H), 2.06 (s, 3H), 
1.71 (s, 3H), 1.67 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 171.2, 141.7, 135.2, 125.2, 
118.6, 68.8, 61.4, 39.0, 25.6, 21.0, 16.4, 13.6. HRMS-ESI m/z 213.1416 [M+H] +, 
C12H21O3 requires 213.1412. 
 
(2E,6E)-8-tert-Butyldimethylsiloxy-3,7-dimethyl2,6-octadienyl acetate (52): 
Imidazole (3.6 g, 53 mmol, 1.2 equiv) and t-butyldimethylchlorosilane (8 g, 53 
mmol, 1.2 equiv) were sequentially added to a solution of alcohol 51 (9.2 g, 43.4 
mmol, 1 equiv) in DCM (217 mL, 0.2M). The mixture was stirred at room 
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temperature for 1 h, quenched with ammonium chloride, and then extracted with 
diethyl ether. The organic phase was washed with brine and dried over Na2SO4. 
Solvent was removed under reduced pressure to give pure 52 (14.1 g, 43.4 mmol, 
100% yield) as a colorless oil.  
1 H NMR (CDCl3, 400 MHz) δ 5.36 (t, J = 7.0 Hz, 1H), 5.35 (t, J = 7.0 Hz, 1H), 4.58 
(d, J = 7.0 Hz, 2H), 4.00 (s, 2H), 2.15 (q, J = 7.4 Hz, 2H), 2.09−2.06 (m, 2H), 2.05 
(s, 3H), 1.70 (s, 3H), 1.59 (s, 3H), 0.90 (s, 9H), 0.05 (s, 6H). 13C NMR (CDCl3, 150 
MHz) δ 171.1, 142.0, 134.9, 123.7, 118.5, 68.6, 61.4, 39.3, 26.0, 25.8, 21.1, 18.5, 
16.5, 13.5, −5.2. HRMS-ESI m/z 327.2272 [M+H] +, C18H35O3Si requires 327.2277. 
 
(2E,6E) -8- ((tert-butyldimethylsilyl) oxy) -3,7-dimethylocta-2,6-dien-1-ol (53): 
Into a flask were added acetate 52 (14.1 g, 43.4 mmol, 1 equiv), MeOH (434 mL, 0.1 
M), and K2CO3 (4.5 g, 32.55 mmol, 0.75 equiv). The mixture was stirred at room 
temperature for 4h, quenched with NH4Cl, and extracted with diethyl ether. The 
combined organic phase was washed with brine and dried over Na2SO4. Solvent was 
removed under reduced pressure to obtain pure alcohol 53 (10.7 g, 37.6 mmol, 87% 
yield), as a colorless oil, which was used for the next step without futher purifications. 
1H NMR (CDCl3, 400 MHz) δ 5.42 (t, J = 6.7 Hz, 1H), 5.36 (t, J = 7.0 Hz, 1H), 4.15 
(d, J = 6.7 Hz, 2H), 4.00 (s, 2H), 2.16 (q, J = 7.5 Hz, 2H), 2.05 (t, J = 7.5 Hz, 2H), 
1.68 (s, 3H), 1.59 (s, 3H), 0.90 (s, 9H), 0.06 (s, 6H). 13C NMR (CDCl3, 150 MHz) δ 
139.5, 134.8, 124.0, 123.7, 68.7, 59.4, 39.3, 26.1, 25.9, 18.6, 16.3, 13.6, −5.1. 
HRMS-ESI m/z 285.2288 [M+H] +, C16H33O2Si requires 285.2250 
 
(2E,6E) -8-(tert-butyldimethylsilyloxy) - 3,7-dimethylocta-2,6- dienal (50): to a 
stirred solution of alcohol 53 (10.7 g, 37.6 mmol, 1 equiv) in DCM/DMSO (2:1, 513 
mL, 0.07M) were added Et3N (26.1 mL, 188 mmol, 5 equiv) and SO3•py (23.9g, 
150.4 mmol, 4 equiv) at room temperature. The mixture was stirred for 1 h and it was 
quenched with NH4Cl and extracted with diethyl ether. The combined organic 
extracts were dried over Na2SO4 and concentrated under reduced pressure. The 
residue was chromatographed on silica gel (cyclohexane/ethyl acetate 9:1) to obtain 
compound 50 (9.8 g, 34.6 mmol, 92% yield), as a pale-yellow oil.  
1H NMR (CDCl3, 400 MHz) δ 0.06 (s, 6 H), 0.92 (s, 9 H), 1.62 (d, J = 2 Hz, 3 H), 
2.17 (s, 3 H), 2.28 (m, 4 H), 4.00 (s, 2 H), 5.38 (m, 1 H), 5.90 (br d, J = 8 Hz, 2H), 
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10.00 (1 H, d, J = 8 Hz, 1 H); 13C NMR (101 MHz, cdcl3) δ 191.18 (s), 163.48 (s), 
135.80 (s), 127.46 (s), 122.12 (s), 68.16 (s), 40.29 (s), 25.91 (s, 3C), 25.15 (s), 17.54 
(s), 13.45 (s), -0.03 (s), -5.31 (s, 2C). HRMS-ESI m/z 283.2101 [M+H] +, C16H31O2Si 
requires 283.2093 
 
Ethyl (4E,8E) -10-((tert-butyldimethylsilyl) oxy) -3-hydroxy-5,9-dimethyl-2-
(prop-1-en-2-yl) deca-4,8-dienoate (55a): to a stirred solution of ethyl-3,3-dimethyl 
acrylate (5.8 ml, 41.8 mmol, 1.2 equiv) in THF, LDA (2M, 41.8 mmol, 1.2 equiv) 
was added dropwise at -78°C. After 10 minutes, compound (50) (9.8 g, 34.8 mmol, 
1 equiv) was added dropwise. After 20 minutes the mixture was quenched with 
NH4Cl and extracted with diethylether. The combined organic layers were dried 
(Na2SO4) and concentrated in vacuo. The residue was chromatographed on silica gel 
(cyclohexane/ethyl acetate 8:2) to obtain compound 55a (11.1 g, 27.1 mmol, 78 % 
yield), as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 5.33 (t, J = 6.8 Hz, 1H), 5.14 (d, J = 9.1 Hz, 1H), 4.90 
(s, 2H), 4.75 (dt, J = 8.9, 4.5 Hz, 1H), 4.20 (q, J = 7.4 Hz, 2H), 3.99 (s, 2H), 3.08 (d, 
J = 8.8 Hz, 1H), 2.54 (d, J = 4.6 Hz, 1H), 2.19 – 2.00 (m, 4H), 1.72 (s, 3H), 1.71 (s, 
3H), 1.59 (s, 3H), 1.27 (t, J = 7.2 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 6H). 13C NMR (101 
MHz, CDCl3) δ 173.23 (s), 140.48 (s), 139.84 (s), 134.74 (s), 124.49 (s), 124.04 (s), 
115.21 (s), 68.69 (s), 68.10 (s), 60.85 (s), 59.63 (s), 39.27 (s), 25.95 (s, 3C), 21.51 
(s), 18.42 (s), 16.79 (s), 14.10 (s), 13.41 (s), 0.03 (s),-5.27 (s, 2C). HRMS-ESI m/z 
411.2935 [M+H] +, C23H43O4Si requires 411.2931 
 
Ethyl (4E,8E)-3,10-bis((tert-butyldimethylsilyl) oxy) -5,9-dimethyl-2-(prop-1-
en-2-yl) deca-4,8-dienoate (61): imidazole (2.2 g, 32.5 mmol, 1.2 equiv) and t-
butyldimethylchlorosilane (4.9 g, 32.5 mmol, 1.2 equiv) were sequentially added to 
a solution of alcohol 55a (11.1 g, 27.1 mmol, 1 equiv) in DCM (160 mL, 0.2M). The 
mixture was stirred at room temperature for 1 h, quenched with ammonium chloride, 
and then extracted with diethyl ether. The organic phase was washed with brine and 
dried over Na2SO4. Solvent was removed under reduced pressure to give pure 61 
(14.2 g, 27.1 mmol, 100% yield) as a colorless oil.  
1H NMR (400 MHz, CDCl3) δ 5.34 (t, J = 6.9 Hz, 1H), 5.02 (d, J = 10.5 Hz, 1H), 
4.93 (s, 1H), 4.83 (s, 1H), 4.77 (t, J = 9.7 Hz, 1H), 4.20 – 4.13 (m, 1H), 4.12 – 4.05 
(m, 1H), 3.99 (s, 2H), 3.07 (d, J = 9.8 Hz, 1H), 2.11 (dd, J = 15.4, 7.2 Hz, 2H), 2.03 
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– 1.97 (m, 2H), 1.70 (s, 3H), 1.67 (d, J = 1.1 Hz, 3H), 1.60 (s, 3H), 1.26 (t, J = 7.1 
Hz, 3H), 0.91 (s, 9H), 0.82 (s, 9H), 0.06 (s, 6H), 0.04 – -0.01 (m, 6H). 13C NMR (101 
MHz, CDCl3) δ 172.31 (s), 139.81 (s), 137.45 (s), 134.65 (s), 126.16 (s), 124.28 (s), 
114.89 (s), 70.00 (s), 68.74 (s), 61.12 (s), 60.34 (s), 39.36 (s), 26.89 (s), 26.0 (s), 
25.95 (s, 2C), 25.65 (s, 2C), 21.94 (s), 18.42 (s), 17.92 (s), 17.04 (s), 14.14 (s), 13.36 
(s), 0.99 (s), -0.02 (s), -4.02 (s), -5.14 (s), -5.28 (s). 
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CHAPTER 6 
 
CONCLUSIONS 
 
Natural products contribute greatly to the discovery of lead compounds for the 
development of new therapeutically active compounds, representing over one-third 
of all FDA-approved new molecular entities (NMEs). It is well known that natural 
sources have been largely studied, in order to search new therapeutic agents, and in 
particular plants have provided the starting material to develop promising drugs for 
the treatment of a broad spectrum of diseases. In this context, the main part of the 
research activity described in my PhD thesis has resulted in the isolation and 
structural elucidation of new natural products, deriving from Apiaceae plants 
belonging to Mediterranean and Iranian flora, to evaluate and enhance their 
pharmacological potential. In particular, the analysis of the polyacetylenic fraction 
obtained from Echinophora platyloba has shown a new interesting modulation of 
TRPA1 channels, which are involved in the mediation of neuropathic and 
inflammatory pain. Polyacetylenes have already shown anti-inflammatory effects, 
mainly related to inhibition of NF-kB or to the modulation of prostaglandin 
catabolism, but the results obtained from the study reported in my thesis, suggest that 
modulation of TRPA1 could be another anti-inflammatory mechanism of 
polyacetylenes worthy of additional studies. 
As regards the phytochemical investigation of Daucus virgatus, the plant has been a 
treasure trove of new molecules with different skeletons, mainly belonging to 
germacranolide-type, a class of natural products never found before in Daucus 
species. The bio-guided fractionation of D. virgatus apolar extract has resulted in the 
isolation of eight new angeloylated germacranolides, showing a promising 
Plasmodium transmission-blocking activity; among all the isolated compounds, 
daucovirgolide G has displayed the highest antimalarial activity and, remarkable, it 
has been also lacking in general toxicity against both normal and tumor cell lines. 
Given the small amounts of daucovirgolide G present in the plant, I spent the last part 
of my PhD period at University College of Dublin, to start a project aiming to the 
total synthesis of this antimalarial metabolite. The synthesis is still in progress and it 
will result in the preparation of the target compound, along with analogues, in order 
to better understand the unknown mechanism of action at molecular level and to 
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perform further in vivo biological studies. In addition, the total synthesis of 
daucovirgolide G could support the stereostructure determined for the natural 
compound, and clarify the relationship between the stereochemistry of the 
germacranolide core and that of the epoxyangeloyl group present in the side chain. 
This project paves the way for a prolific collaboration leading to bridge the gap 
between the natural procuts research and drug discovery. Lastly, the complete 
phytochemical investigation of D. virgatus afforded additional secondary 
metabolites evaluated for their antiproliferative activity, against three human cell 
lines, A375 (melanoma), MCF-7 (breast adenocarcinoma), and HACAT 
(keratinocyte). All the three tested new sesquiterpenoids isolated from the plant 
showed a significantly higher antiproliferative activity against tumor cell lines 
compared to that against non-tumor keratinocytes, that is worthy of further 
investigation. In conclusion, it is important to underline that the research in the 
natural products field can be considered as a great opportunity to discover new 
candidates for drug discovery, but also a source of new challenges for organic 
chemists; indeed, the structural diversity associated to secondary metabolites coming 
from natural sources, represents an appealing opportunity to devise new synthetic 
methodogies, which constitute the driving force to develop synthetic routes for the 
total synthesis of natural products. 
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SPECTRAL DATA 
 
Spectral data for CHAPTER 3 
 
1H spectrum (500 MHz) of echinophorin D (1) in CDCl3 
 
 
 
 
 
 
 
 
 
 
 
COSY spectrum (500 MHz) of echinophorin D (1) in CDCl3 
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HMBC spectrum (500 MHz) of echinophorin D (1) in CDCl3 
 
 
 
 
 
HSQC spectrum (500 MHz) of echinophorin D (1) in CDCl3 
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Spectral data for CHAPTER 4 
 
1H spectrum (500 MHz) of daucovirgolide A (1) in CDCl3 
 
 
COSY spectrum (500 MHz) of daucovirgolide A (1) in CDCl3 
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Spectral data Chapter 7 
HMBC spectrum (500 MHz) of daucovirgolide A (1) in CDCl3 
 
 
 
 
 
HSQC spectrum (500 MHz) of daucovirgolide A (1) in CDCl3 
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Spectral data Chapter 7 
1H spectrum (500 MHz) of daucovirgolide B (2) in CDCl3 
 
 
 
 
 
COSY spectrum (500 MHz) of daucovirgolide B (2) in CDCl3 
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Spectral data Chapter 7 
HMBC spectrum (500 MHz) of daucovirgolide B (2) in CDCl3 
 
 
 
 
 
 
HSQC spectrum (500 MHz) of daucovirgolide B (2) in CDCl3 
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Spectral data Chapter 7 
1H spectrum (500 MHz) of daucovirgolide C (3) in CDCl3 
 
 
 
 
 
 
COSY spectrum (500 MHz) of daucovirgolide C (3) in CDCl3 
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Spectral data Chapter 7 
HMBC spectrum (500 MHz) of daucovirgolide C (3) in CDCl3 
 
 
 
 
 
 
HSQC spectrum (500 MHz) of daucovirgolide C (3) in CDCl3 
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Spectral data Chapter 7 
ROESY spectrum (500 MHz) of daucovirgolide C (3) in CDCl3 
 
 
 
 
 
 
1H spectrum (500 MHz) of daucovirgolide D (4) in CDCl3 
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Spectral data Chapter 7 
COSY spectrum (500 MHz) of daucovirgolide D (4) in CDCl3 
 
 
 
 
 
 
HMBC spectrum (500 MHz) of daucovirgolide D (4) in CDCl3 
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Spectral data Chapter 7 
HSQC spectrum (500 MHz) of daucovirgolide D (4) in CDCl3 
 
 
 
 
 
 
1H spectrum (500 MHz) of daucovirgolide E (5) in CDCl3 
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Spectral data Chapter 7 
COSY spectrum (500 MHz) of daucovirgolide E (5) in CDCl3 
 
 
 
 
 
 
 
HMBC spectrum (500 MHz) of daucovirgolide E (5) in CDCl3 
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Spectral data Chapter 7 
HSQC spectrum (500 MHz) of daucovirgolide E (5) in CDCl3 
 
 
 
 
 
 
 
ROESY spectrum (500 MHz) of daucovirgolide E (5) in CDCl3 
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Spectral data Chapter 7 
1H spectrum (500 MHz) of daucovirgolide F (6) in CDCl3 
 
 
 
 
 
 
 
COSY spectrum (500 MHz) of daucovirgolide F (6) in CDCl3 
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Spectral data Chapter 7 
HMBC spectrum (500 MHz) of daucovirgolide F (6) in CDCl3 
 
 
 
 
 
 
 
HSQC spectrum (500 MHz) of daucovirgolide F (6) in CDCl3 
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Spectral data Chapter 7 
ROESY spectrum (500 MHz) of daucovirgolide F (6) in CDCl3 
 
 
 
 
 
 
 
1H spectrum (500 MHz) of daucovirgolide G (7) in CDCl3 
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Spectral data Chapter 7 
COSY spectrum (500 MHz) of daucovirgolide G (7) in CDCl3 
 
 
 
 
 
 
 
HSQC spectrum (500 MHz) of daucovirgolide G (7) in CDCl3 
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Spectral data Chapter 7 
1H spectrum (500 MHz) of daucovirgolide H (8) in CDCl3 
 
 
 
 
 
 
 
COSY spectrum (500 MHz) of daucovirgolide H (8) in CDCl3 
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Spectral data Chapter 7 
HMBC spectrum (500 MHz) of daucovirgolide H (8) in CDCl3 
 
 
 
 
 
 
 
1H spectrum (500 MHz) of vaginatin B (14) in CDCl3 
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Spectral data Chapter 7 
COSY spectrum (500 MHz) of Vaginatin B (14) in CDCl3 
 
 
 
 
 
 
 
1H spectrum (500 MHz) of compound (15) in CDCl3 
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Spectral data Chapter 7 
COSY spectrum (500 MHz) of compound (15) in CDCl3 
 
 
 
 
 
 
 
HMBC spectrum (500 MHz) of compound (15) in CDCl3 
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Spectral data Chapter 7 
HSQC spectrum (500 MHz) of compound (15) in CDCl3 
 
 
 
 
 
 
 
ROESY spectrum (500 MHz) of compound (15) in CDCl3 
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Spectral data Chapter 7 
1H spectrum (500 MHz) of elemavirgolide (16) in CDCl3 
 
 
 
 
 
 
 
COSY spectrum (500 MHz) of elemavirgolide (16) in CDCl3 
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Spectral data Chapter 7 
HMBC spectrum (500 MHz) of elemavirgolide (16) in CDCl3 
 
 
 
 
 
 
 
HSQC spectrum (500 MHz) of elemavirgolide (16) in CDCl3 
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Spectral data Chapter 7 
Spectral data for CHAPTER 5 
 
1H spectrum (500 MHz) of compound (50) in CDCl3 
 
 
 
13C spectrum (500 MHz) of compound (50) in CDCl3 
 
 
 
 
 
  
 
141 
 
  
Spectral data Chapter 7 
1H spectrum (500 MHz) of compound (55a) in CDCl3 
 
 
 
 
13C spectrum (500 MHz) of compound (55a) in CDCl3 
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Spectral data Chapter 7 
1H spectrum (500 MHz) of compound (61) in CDCl3 
 
 
 
 
13C spectrum (500 MHz) of compound (61) in CDCl3 
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Spectral data Chapter 7 
 
1H spectrum (500 MHz) of compound (60) in CDCl3 
 
 
